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1. Introduction 
One of the most fundamental functions of a cell is the transmission of genetic information to 
the next generation, with high fidelity. On the face of it, this seems a challenging task given 
that cells in the human body are constantly exposed to thousands of DNA lesions every day 
both from endogenous and exogenous sources. Yet, for long periods of time, the DNA 
sequences are one of the most invariable and stable components of a cell, a task achieved by 
an arsenal of DNA damage detection and repair machinery that detects and fixes DNA 
lesions with high fidelity at each and every round of cell division.  In this chapter, we 
describe how normal cells cope with DNA damage and the manner in which a defective 
DNA damage response can lead to human disease and aging. 
2. The types and sources of DNA damage 
All livings cells of the human body have to constantly contend with DNA damage. Due to 
its chemical structure itself, the DNA is sensitive to spontaneous hydrolysis which leads to 
damage in the form of abasic sites and base deamination. Single strand breaks (SSBs) and 
oxidative damage such as 8-oxoguanine lesions in DNA are generated by endogenous by-
products of metabolism like reactive oxygen species (ROS) and their highly reactive 
intermediates. For example, it is estimated that about 100-500 8-oxoguanine lesions form per 
day in a human cell (Lindahl, 1993). The formamidopyrimidine lesions, 2,6-diamino-4-
hydroxy-5-formamidopyrimidine (FapyG) and 4,6-diamino-5-formamidopyrimidine are 
also formed at similar rates as 8-oxoG after oxidative stress.  Spontaneous DNA alterations 
may also arise due to dNTP misincorporation during DNA replication. Put together, it is 
estimated that each human cell can face up to 105 spontaneous DNA lesions per day 
(Maynard et al., 2009). 
Apart from endogenous sources, DNA can also be damaged by exogenous agents from the 
environment. These include physical genotoxic stresses such as the ultraviolet light (mainly 
UV-B: 280-315 nm) from sunlight which can induce a variety of mutagenic and cytotoxic 
DNA lesions such as cyclobutane-pyrimidine dimers (CPDs) and 6-4 photoproducts (6-
4PPs) (Rastogi et al., 2010). DNA damage in the form of double strand breaks (DSBs) can be 
incurred as a result of medical treatments like radiotherapy, ionising radiation (IR) exposure 
from cosmic radiation or as a result of the natural decay of radioactive compounds. For 
example, uranium decay produces radioactive radon gas, which accumulates in some 
houses to cause an increased incidence of lung cancer (Jackson and Bartek, 2009).  Nuclear 
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disasters like the Chernobyl nuclear disaster, nuclear detonations during World War II or 
more recently, the radiation leakage from the Fukushima power plant in Japan are examples 
of other sources of severe exposure to exogenous radiation. Chemical sources of DNA 
damage include chemotherapeutic drugs used in cancer therapy or for other medical 
conditions.  Alkylating agents such as methyl methanesulfonate (MMS) induce alkylation of 
bases, whereas drugs such as mitomycin C, cisplatin and nitrogen mustard cause DNA 
interstrand cross links (ICLs), and DNA intrastrand cross links.  Chemotherapeutic drugs 
like camptothecin and etoposide are topoisomerse I and II inhibitors respectively, and give 
rise to SSBs or DSBs by trapping topoisomerase–DNA complexes. Other exogenous DNA-
damaging sources, that are carcinogenic as well, are foods contaminated with fungal toxins 
such as the aflatoxin and overcooked meat products containing heterocyclic amines. 
Another common source of environmental mutagen is tobacco smoke, which generates 
DNA lesions in the form of aromatic adducts on DNA and SSBs (Jackson and Bartek, 2009). 
3. DNA repair pathways 
To maintain genomic integrity, a cellular machinery composed of multi-protein complexes 
that are capable of detecting and signalling the presence of DNA lesions and delaying cell 
cycle progression to promote DNA repair is activated, called as the DNA damage response 
(DDR) (Harper and Elledge, 2007). To accomplish DNA repair, cells utilise biochemically 
distinct pathways specific of the DNA lesion, which are integrated with appropriate 
signalling systems to delay cell division until the completion of repair (Figure.1). Small 
chemical alterations caused by the oxidation of bases is detected and repaired by the base 
excision repair system (BER), through the direct excision of the damaged base. DNA 
replication errors or polymerase slippage errors that commonly result in single base 
mismatches and insertion-deletion loops are corrected by the mismatch repair system 
(MMR). Lesions such as pyrimidine dimers and intrastrand cross links are corrected by the 
nucleotide excision repair (NER) pathway. SSBs are removed by the SSB repair pathway 
whereas DSBs are repaired by the DSB repair systems, which itself could be either by 
homologous recombination (HR) or non-homologous end joining (NHEJ) pathway (Ciccia 
and Elledge, 2010). 
 
 
Fig. 1. Summary of DNA repair pathways 
3.1 Base excision repair and single strand break repair 
Base excision repair (BER) is the major pathway responsible for handling the mutagenic and 
cytotoxic effects of DNA damage that can arise due to spontaneous hydrolytic, oxidative, 
and non-enzymatic alkylation reactions. (Wilson and Bohr, 2007). This pathway focuses on 
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DNA lesions that do not tend to cause structural distortions of the DNA double helix. The 
BER target lesions can be classified as oxidised/reduced bases such as 8-oxo-G/FapyG, 
methylated bases, deaminated bases or bases mismatches. There are two types of BER: short 
patch and long patch. During short patch BER, only the damaged nucleotide is replaced, 
whereas in long patch BER, 2-6 new nucleotides are incorporated. 
The very first step in BER involves the use of DNA glycosylases that cleave the N-glycosyl 
bond between the damaged base and sugar to generate an abasic site, called as the AP 
(apurinic/apyrimidinic) site. Similar AP sites may also arise due to the spontaneous 
depurination or depyrimidination of bases. The DNA glycosylases that perform this 
function are classified as monofunctional or bifunctional, depending on their mode of 
action. Monofunctional glycosylases such as UNG only possess the glycosylase activity and 
therefore a second enzyme called the APE1 lyase is required to cut base-free deoxyribose to 
generate the 5’-deoxyribose phosphate termini (dRP). The next step involves the action of 
DNA polymerase β (polβ) which removes the dRP group left behind by APE1 incision in the 
short-patch pathway. However, if the 5’ terminal is refractory to polβ activity, strand 
displacement synthesis is required in order to incorporate multiple nucleotides by long-
patch pathway. In this case, several enzymes such as proliferating cell nuclear antigen 
(PCNA), FEN1 and polβ and/or polδ/ε act together to remove the blocking terminus. The 
final step of BER consists of ligation of the remaining nick, by either Lig1 alone or Lig3–
XRCC1 complex (Maynard et al., 2009). 
SSB repair pathway is a major pathway responsible for the repair of SSBs that arise directly 
as a result of ROS-induced disintegration of oxidized deoxyribose or genotoxic stresses such 
as IR. SSBs may also arise spontaneously due to the erroneous activity of DNA 
topoisomerase 1 (TOP1). TOP1 creates a cleavage complex intermediate which contains a 
DNA nick to allow DNA relaxation during DNA replication and transcription. Usually, the 
nick generation is transient and is rapidly sealed by TOP1. However, if the nick 
inadvertently collides with RNA polymerase, SSBs may be generated in the process. In 
addition to the above scenarios where SSBs are generated directly within cells, SSBs may 
also arise indirectly as BER intermediates due to the lyase activity of bifunctional 
glycosylases such as OGG1 and NEIL1.   
Single strand break repair (SSB) involves the activation of PARP (poly ADP ribose 
polymerase) family members PARP1 and PARP2, which act as sensors of SSBs, through the 
two PARP1 zinc finger motifs (Caldecott, 2008).  Upon activation of PARP1 and PARP2, 
poly (ADP-ribose) chains are synthesized within seconds, and assembled on target proteins 
such as histone H1 and H2B and PARP1 itself (Schreiber et al., 2006). Histone PARylation 
contributes to chromatin reorganization and helps in the recruitment of DNA repair and 
chromatin remodelling proteins to DNA damage sites. Three types of PAR-binding motifs 
have been identified: the PBZ (PAR-binding zinc finger), the macrodomain and an 8 amino 
acid basic residue-rich cluster. Many DDR factors such as p53, XRCC1, Lig3, MRE11 and 
ATM have the 8 amino acid basic residue-rich cluster, whereas macrodomains containing 
proteins include PARP9, PARP14, PARP15, the histone variant macroH2A1.1, and the 
chromatin remodeling factor ALC1. PBZ motifs have been identified in the nucleases APLF 
and SNM1 and in the cell cycle protein CHFR.  
Once SSBs are detected, they undergo end processing, where the 3’ and/or 5’ termini of 
SSBs are restored to conventional 3’hydroxyl and 5’ phosphate moieties for gap filling and 
DNA ligation to occur. XRCC1 has a particularly important role during DNA end 
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processing step, since XRCC1 directly interacts with enzymes such as  pol β, PNK 
(polynucleotide kinase) and the nucleases  APTX  and indirectly with DNA ligase III α and 
TDP1 (tyrosyl-DNA phosphodiesterase) to facilitate end processing. Damage termini 
present at indirect BER-induced SSB are repaired by APE1, Pol β, PNKP and APTX. Direct 
sugar damage-induced SSBs are repaired by APE1, PNKP and APTX. SSBs generated by 
TOP1 are repaired by TDP1. Finally, end processing is followed by gap filling and ligation, 
and the enzymes utilized during these two steps overlap with BER (as described above). 
It is interesting that ~30% of all human tumors examined express a variant form of DNA 
polymerase β (Starcevic et al., 2004) Moreover, at least two proteins, TDP1 and APTX, 
involved in SSB repair are mutated in an inherited form of human neurodegenerative 
disease (discussed in Section 5.1). 
3.2 Mismatch repair 
The replication of DNA sequences in the S phase of cell cycle is subjected to a low but 
significant level of error that includes the inadvertent incorporation of chemically altered 
nucleotides in place of the normal counterparts.  The cell has two main strategies to detect 
and remove the miscopied nucleotides. In a ‘proofreading’ type of monitoring executed by 
the DNA polymerase δ (pol-฀δ), the stretch of DNA that has been newly synthesized is 
scanned, and if misincorporation of nucleotides is detected, the enzyme uses it 3’-5’ 
exonuclease activity to remove the aberrant nucleotide and resynthesize the DNA stretch. 
However, if the miscopied DNA sequence is overlooked by DNA pol-δ, the MMR pathway 
is activated that detects and corrects misincorporated nucleotides. The action of this 
pathway becomes especially critical in regions of DNA that carry repetitive sequences such 
as mono or dinucleotide repeats. The resulting base substitution mismatches and insertion-
deletion mismatches (IDLs) may escape correction by the proofreading mechanism 
described above, making the repair of such defects the prime function of the MMR 
machinery (Kunkel and Erie, 2005). 
The ‘Mut’ proteins are the principle active components of the mismatch repair pathway 
(Kolodner and Marsischky, 1999). The main function of the Mut proteins lies in the ability to 
detect bulges and loops in the newly formed DNA and in being able to distinguish between 
recently synthesized DNA from the complementary parent strand. In mammalian cells, two 
components of the MMR apparatus, MutS and MutL collaborate to correct mismatched 
DNA. MutS homologs form two major heterodimers, Msh2/Msh6 (MutSα) and Msh2/Msh3 
(MutSβ) which scan for the mismatched base on the newly formed daughter strand and 
bind directly to the mutated DNA. The main difference between the two MutS complexes is 
that MutSǂ pathway is mainly involved in the repair of base substitution and small loop 
mismatches, while the MutSǃ pathway is also involved in large loop repair. After the 
recruitment of MutS, MutL dimer is loaded to the mutated site through its binding to the 
MutS-DNA complex. MutL has three forms designated as MutLα, MutLβ, and MutLγ. The 
MutLǂ complex is made of two subunits MLH1 and PMS2, the MutLǃ heterodimer is made 
of MLH1 and PMS1, while MutLǄ is made of MLH1 and MLH3. MutLǂ is an endonuclease 
that facilitates strand-discrimination and nicks the discontinuous strand of the mismatched 
duplex in a PCNA, RFC and ATP-dependent manner. Lastly, the excision reaction is 
performed by the 5′–3′ single-stranded exonuclease EXO1, whose exonuclease activity is 
increased by its direct interaction with MutSǂ. The resulting fragment is excised and a fresh 
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attempt at resynthesizing DNA using DNA pol-δ฀is made using the parent strand as the 
template (Fukui, 2010; Larrea et al., 2010). 
The MMR pathway is particularly important in mammals, where the mutator phenotype 
conferred by loss of MMR activity contributes to the initiation and promotion of multistage-
carcinogenesis (Venkatesan et al., 2006) 
3.3 Nucleotide excision repair 
The activation of NER pathway seems to require two distinct structural changes in DNA: a 
significant distortion to the native conformation of DNA and the presence of a chemically 
altered base. NER is accomplished by a large multisubunit complex composed of almost two 
dozen subunits. NER comprises of two distinct subpathways that mainly differ in the 
molecular mechanism used to identify the damaged base. Global genome repair (GGR) 
repairs DNA damage throughout the genome, whereas transcription-coupled repair (TCR) 
repairs lesions in regions that are undergoing transcription (Nouspikel, 2009). 
Historically, the NER pathway was discovered through the study of a human syndrome 
involving a severe burning of the skin after only a minimal exposure to sun light. These 
individuals show dry, parchment like skin (Xeroderma) and freckles (pigmentosa). 
Individuals suffering from Xeroderma Pigmentosa (XP) have a 1000-fold greater risk of 
developing skin cancers and inherited defects in any of the so-called XP genes cause this 
syndrome. Subsequently, elegant somatic cell genetic experiments were performed and 
seven genetic complementation groups of the human XP, designated XPA to XPG were 
identified in mammalian cells. According to current understanding, two independent 
complexes, one composed of the DDB1/DDB2 heterodimer, and the other containing the 
XPC/HR23B/Centrin 2 proteins are required for the early steps of base damage recognition 
during NER (Guo et al., 2010; Nouspikel, 2009). 
UV-damaged DNA-binding protein (UV-DDB) is a heterodimeric complex composed of 
DDB1 and DDB2 which upon binding to UV-damaged sites activates a UV-DDB-associated 
ubiquitin ligase complex that recruits XPC protein to the lesion and promotes ubiquitination 
of DDB2 and XPC proteins (Sugasawa et al., 2005). Upon polyubiquitination, DDB2 loses its 
ability to bind to UV-irradiated DNA, whereas XPC upon ubiquitination shows increased 
DNA binding. In turn, XPC recruits the multiprotein transcription-repair complex called as 
the TFIIH (transcription factor IIH). Subsequent recruitment of RPA and XPA drive 
detachment of cyclin-dependent kinase activating (CAK) subcomplex of TFIIH which is 
essential for GGR. The two helicases within the TFIIH complex (XPB and XPD) unwind the 
DNA by about 20 bp around the damage to form a stable complex called pre-incision 
complex 1 (PIC1). Localized unwinding around the damaged base then leads to the exit of 
XPC-HR23 and the entry of XPG to form PIC2. Finally, XPF-ERCC1 is recruited to form 
PIC3. At each of these steps ATP is hydrolyzed, and the free energy of ATP hydrolysis is 
used to unwind the helix as well as to amplify the damage recognition specificity of the 
enzyme system. Within PIC3, XPG and the ERCC1/XPF complex are both structure-specific 
endonucleases that carry out dual excision and cut the damaged strand of DNA 3′ and 5′ to 
the lesion, respectively. This generates a single-stranded oligonucleotide 24–32 nucleotides 
in length. The incisions are asymmetrical, such that the 3′ incision occurs 2 to 8 nucleotides 
from the damaged base and the 5′ incision occurs 15 to 24 nucleotides from the damaged 
base. The resulting gap is filled in by the combined actions of DNA polymerase ǅ or ǆ, 
proliferating cell nuclear antigen (PCNA), RPA, and DNA ligase I (or a complex of 
XRCC1and DNA ligase III) (Hanawalt and Spivak, 2008). 
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Bulky lesions consisting of UV-induced pyrimidine dimers in transcribed regions can lead to 
RNA polymerase II stalling, evoking the activation of TCR. In TCR, the stalled RNA 
polymerase is removed and DNA damage is repaired, through a process initiated by the 
Cockayne syndrome proteins, CSA and CSB. The CSA protein belongs to the ‘WD repeat’ 
family of proteins and exhibits structural and regulatory roles while CSB protein which is an 
ATP-dependent chromatin remodelling factor in the SWI/SNF family. CSB, in turn recruits 
additional factors such as the histone acetytransferase p300, the CSA-DDB1 E3 
ubiquitin/COP9 signalosome complex (O'Connell and Harper, 2007). Similar to GGR, the 
subsequent steps involve the binding of TFIIH and XPA/RPA to the lesion and the 
nucleases XPG and XPF/ERCC1 carry out the incision 3’and 5’ to the damaged lesion. The 
generated oligonucleotide is removed and the gap is filled in by the combined action of 
DNA polymerases ǅ or ǆ, PCNA, RPA, and DNA ligase I or XRCC1/ DNA ligase III. 
3.4 DNA replication stress and ATR 
Replication stress is a unifying term used to denote large unprotected regions of ssDNA 
generated during the course of DNA replication or formed at the resected region of DSBs 
(Lopez-Contreras and Fernandez-Capetillo, 2010). Both situations converge with the 
generation of a RPA-coated ssDNA intermediate which is the triggering signal for the DNA 
replication checkpoint. The ssDNA-RPA complex plays two critical roles: it recruits ATR by 
directly binding to the ATR partner, ATRIP. Secondly, it recruits and activates the Rad17 
clamp loader which then loads the PCNA-like heterotrimeric ring 9-1-1 (Rad9-Hus1-Rad1) 
complex to DNA.  The 911 complex binds to the ATR activator TopBP1, thus bringing it in 
close proximity to ATR-ATRIP, leading to ATR activation. Once activated, ATR initiates the 
DNA replication checkpoint through the phosphorylation of its downstream substrates. In 
addition to replication checkpoint signalling, ATR is also required for stabilization of stalled 
replication forks. In the absence of ATR, forks undergo a ‘collapse’ and are unable to resume 
replication upon the withdrawal of replication stress (Friedel et al., 2009). The absence of 
ATR also results in a specific type of genomic instability, named as DNA Fragile site 
expression. DNA fragile sites (DFS) are large (>100 Kb) genomic regions that exhibit breaks 
under conditions of replication stress. DFS sites are ‘hot spots’ for sister chromatid 
exchanges and are involved in gene amplification events via a breakage-fusion-bridge cycle. 
Breakage at DFS is associated with several cancers (Dillon et al., 2010). 
3.5 Interstrand cross link repair (ICL repair) 
ICLs are generated by cross linking agents like mitomycin C and these lesions covalently 
connect the two strands of DNA to form a barrier to replication fork progression. Important 
components of the ICL repair pathway are 13 genes mutated in the genetic syndrome, 
Fanconi anemia (FA). FA is an autosomal recessive cancer predisposition disorder 
characterized by progressive bone marrow failure, congenital developmental defects, 
chromosomal abnormalities and hypersensitivity to ICL agents (Kitao and Takata, 2011). 
The gene products of FA constitute a common pathway called the FA pathway, whose main 
role is in the repair of ICL lesions to maintain genomic integrity (Moldovan and D'Andrea, 
2009). Eight of the FA proteins (FANCA, B, C, E, F, G, L and M) form the so-called FA core 
complex, an E3 ubiquitin ligase that monoubiquitinates downstream FANCD2-FANCI 
dimer. The core complex also incorporates FAAP100 and FAAP24 and the heterodimer 
MHF1/MHF2 as crucial components. Upon monoubiquitination, the ID complex 
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accumulates at the sites of crosslinks and co-localizes with three additional FA proteins, 
Brca2 (FANCD), PALB2 (FANCN), and BACH1 (FANCJ). Monoubiquitinated ID complex is 
required for the incision and translesion synthesis steps of ICL repair by promoting the 
recruitment of DDR factors required for ICL repair (Moldovan and D'Andrea, 2009).  
Recently, another level of regulation was revealed in the FA pathway, in that ID complex is 
phosphorylated first by ATR and this step was shown to be critical for further 
monoubiquitination by the core complex.  Subsequently, factors required for HR are also 
recruited to repair the DSBs generated during the repair process. Thus, ICL repair requires 
the coordinated recruitment and concerted action of several DNA repair pathways. 
3.6 Double strand break repair 
DNA double strand breaks are the most deleterious type of DNA damage and cells have 
evolved at least four types of repair pathways to detect and correct DSBs. These pathways 
include homologous recombination (HR), non-homologous end joining (NHEJ), alternative 
NHEJ pathway.  The main factor influencing pathway choice is the extent of DNA 
processing. While NHEJ does not require DNA end resection, HR and  alternative NHEJ 
pathways are  dependent on end resection (Ciccia and Elledge, 2010). 
NHEJ is an error-prone process, where broken ends are recognised and sealed together and 
mainly occurs in G0, G1 and early S phase of the cell cycle and requires the DNA-PK (DNA 
protein kinase) complex and the Lig4 complex (Lieber, 2010). The DNA-PK complex consists 
of the Ku70 and Ku80 heterodimer which recognises and binds to the DSB and recruits 
DNA-PKcs, the catalytic subunit of DNA-PK. Following DSB binding, DNA-PKcs 
autophosphorylation on the six-residue ABCDE cluster (T2609) causes destabilization of the 
DNA-PKcs interaction with DNA thus providing access to end processing enzymes such as 
ARTEMIS (Goodarzi et al., 2006). On the other hand, to prevent excessive end processing, 
DNA-PKcs is also autophosphorylated at the five-residue cluster called as the PQR cluster at 
S2056, which helps protect DNA ends. Thus, two reciprocally acting phosphorylation 
clusters regulate end processing by DNA-PKcs (Cui et al., 2005).  
Following the recognition of DSBs, ends must be transformed into 5’phosphorylated 
ligatable ends to complete repair. One key enzyme required for end processing is ARTEMIS, 
which might be recruited to DSBs through its ability to interact with DNA-PKcs. End 
processing is also carried out by APLF nucleases and the PNK kinase/phosphatase prior to 
ligation (Mahaney et al., 2009). Next, the end processing of complex lesions might lead to the 
generation of gaps which are filled in by DNA polymerase Ǎ, polymerase ǌ and terminal 
deoxyribonucleotidyltransferase. The final step involves the ligation of DNA ends, a step 
carried out by X4-L4 (a complex containing XRCC4, DNA ligase IV and XLF) (Hartlerode 
and Scully, 2009). 
Interestingly, when the classical NHEJ pathway is inhibited, an alternative end-joining 
pathway operates in cells. This substitution is called as alternative end joining (alt-EJ), 
backup NHEJ (B-NHEJ) or microhomology mediated end joining (MMEJ) (Lieber and 
Wilson, 2010). This pathway functions even in the absence of classical NHEJ factors such as 
Ku, XRCC4 or DNA ligase IV.  For example, the alt-NHEJ pathway is robustly activated in 
mice lacking X4-L4. Alt-NHEJ is mediated by the annealing of ssDNA microhomology 
regions followed by LIG3-dependent DNA end ligation (Ciccia and Elledge, 2010; 
Hartlerode and Scully, 2009). Microhomologies are short stretches of complementary 
“microhomology” sequences (1–10 base pairs) that often appear at repair junctions. This 
suggests that even limited base pairing between two ends of a double-strand break is 
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exploited during alt-NHEJ repair (Lieber and Wilson, 2010). Alt-NHEJ pathway is error-
prone and frequently results in small deletions/insertions around the region of double 
strand breaks or could even result in deleterious translocations (Zhang and Jasin, 2011). 
Unlike NHEJ, HR is an error-free process that involves the use of the undamaged 
homologous sister chromatid as the template to facilitate DNA repair of the damaged strand 
and is carried out in cells that are in the late S and G2 phases of cell cycle (Moynahan and 
Jasin, 2010). Homologous recombination (HR) provides an important mechanism to repair 
double strand breaks during mitosis and meiosis. Defective HR can potentially transform 
cells by disrupting their genomic integrity. HR involves the detection of DSB by the MRN 
(MRE11-Rad50-NBS1) complex which promotes activation of ATM (Ataxia-telangiectasia 
mutated). In addition to stabilizing DNA ends, MRE11 has endonuclease and exonuclease 
activities which are important to mediate 5’-3’ resection along with CtIP to generate single 
strand DNA (ssDNA). ssDNA is coated by the ssDNA-binding protein, RPA which is a 
heterotrimeric complex (RPA1, RPA2, RPA3) that stabilizes ssDNA regions generated 
during both DNA replication, repair and recombination. At the double strand break, the 
RPA-coated ssDNA recruits ATR-ATRIP to chromatin, an event critical for the activation of 
the ATR-chk1 pathway. Similar to the trimeric RPA complex, the newly identified human 
ssDNA binding protein, hSSB1 is thought play a role in checkpoint activation and repair 
(Richard et al., 2008). The next critical step in HR is the assimilation of Rad51 to ssDNA in a 
Brca2 and PALB2 (Partner and localizer of Brca2) dependent manner to form the Rad51-
coated nucleoprotein filament. Rad51-mediated homology search and strand invasion 
follows where the Rad51 recombinase utilizes the sister chromatid as the homologous 
template and together with Rad51 paralogs (Xrcc2, Xrcc3, Rad51L1, Rad51L2 and Rad51L3), 
Rad52 and Rad54 promotes strand invasion and recombination. Strand invasion and 
migration involve the formation of a structure termed as the Holliday junction. Following 
DNA polymerase δ-mediated DNA synthesis, resolution of Holliday junction occurs via 
Rad54/Mus81/Emc1 and Rad51C/Xrcc3 (San Filippo et al., 2008). 
It is now becoming increasingly clear that the choice between the various DNA repair 
pathways is dictated by negative regulation of on one pathway by another. For example, 
DSB resection promoted by CtIP is inhibited by 53BP1 (Bunting et al., 2010). 53BP1 itself 
promotes NHEJ by increasing the stability of DSBs during ligation. Another example of this 
regulation was highlighted by a recent study where defective DSB resection in Brca1 mutant 
cells results in NHEJ-dependent chromosomal rearrangements which could be overcome by 
53BP1 loss, suggesting that Brca1 might somehow overcome 53BP1 function at DSBs to 
promote HR (Bunting et al., 2010). Also, abnormal activity of alt-NHEJ in the absence of 
NHEJ induces chromosomal translocation in mammalian cells (Simsek and Jasin, 2010). 
Thus, the right choice of DSB repair pathways can be a critical determinant of genomic 
stability and alterations in the appropriate repair pathway choice can lead to DSB repair 
defects with deleterious consequences. 
3.7 Double strand break signalling 
Amongst the various classes of DNA repair, perhaps the best studied pathway with respect 
to DNA lesion sensing and signalling is the DSB repair signalling response. The response to 
DSBs has been characterised by the rapid localization of repair factors to DSB sites into 
subnuclear foci called ionizing radiation-induced foci (IRIF) (Bekker-Jensen and Mailand, 
2010). At a more mechanistic level, the DDR proteins can be divided into three major classes 
www.intechopen.com
 DNA Repair, Human Diseases and Aging 
 
11 
of proteins that act together to translate the DNA damage signal into an appropriate 
response. These consist of (a) sensor proteins that recognize abnormal DNA lesions and 
initiate the signalling cascade (b) transducers that amplify the damage signal and (c) 
effectors proteins that participate in a number of downstream pathways such as cell cycle, 
apoptosis and senescence (Figure 2: DNA damage signalling and response) (Jackson and 
Bartek, 2009). 
 
 
Fig. 2. Basic organization of the DNA damage response: Sensors, transducers and effectors 
3.7.1 Sensing the damage 
The efficient sensing of DSBs is achieved by Mre11-Rad50-Nbs1 (MRN) protein complex 
(Stracker and Petrini, 2011). The MRE11 (Meiotic Recombination 11) protein is an 
evolutionarily conserved protein that is involved in HR, NHEJ, meiosis and in the 
maintenance of telomeres. RAD50 is a homolog of S.cerevisiae Rad50 and is a member of the 
structural maintenance of chromosome (SMC) protein family. The third protein in the MRN 
complex is NBS1 (Nijmegen breakage syndrome 1) protein also known as Nibrin and p95. 
Structural and biochemical studies have elucidated the architecture of the MRN complex 
and have proposed the biochemical events that lead to the activation of the DDR. The key 
protein in the MRN complex is the Mre11 homodimer. This protein has the ability to bind 
free DSBs and also has an intrinsic 3’-5’ exonuclease activity that can help in the resection of 
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broken ends. The Mre11 dimer can interact with two molecules of Rad50 and with the 
scaffolding protein Nbs1. The extended coiled-coil domains of Rad50 permit it to extend out 
from DNA breaks and bridge with another Rad50 protein through the Zn2+-binding CXXC 
motif, like a ‘hook’. Thus, Rad50 might act as a molecular tether to bridge the DSBs. 
The MRN complex interacts with the N-terminal of ATM and recruits it to DSBs (Lee and 
Paull, 2004). ATM belongs to the phosphatidylinositol-3-like kinase-related kinases (PIKK) 
family and plays an important role in the propagation of the initial DSB lesion by 
phosphorylating a number of downstream substrates. The PIKK family of proteins have a 
conserved kinase domain and three other domains: FAT (FRAP-ATM-TRRAP) domain, 
FATC domain (FRAP-ATM-TRRAP-C-terminal) and the PIKK regulatory domain that 
regulate the kinase activity of the protein. Apart from ATM, the other two PIKK proteins 
essential for DNA damage signalling are ATR (ATM and Rad3 related) and DNA-PKcs. 
ATM and DNA-PKcs are primarily involved in the signalling of DSBs and ATR is mainly 
required in response to stalled DNA replication forks. The interaction between the C-
terminus of NBS1 and ATM leads to the recruitment of ATM to DSBs leading to its 
activation. In undamaged cells, ATM forms inactive dimers or multimers. However, upon 
the induction of DSBs, ATM is autophosphorylated at serine 1981, leading to its dissociation 
into activated monomers (Bakkenist and Kastan, 2003).  Apart from ser1981, ATM is also 
autophosphorylated at serine 367 and serine 1983 and mutations at these sites reduce ATM 
activity. However, observations that transgenic mice carrying alanine substituted 
autophosphorylation serine sites 1987, 367 and 1899 of ATM (corresponding to human ATM 
serine 1981, 367 and 1893) display normal ATM-dependent responses, brought into question 
the function of ATM autophosphorylation in vivo (Daniel et al., 2008). This issue has been 
reconciled with the observation that autophosporylation of ATM at 1981 is not needed for 
the initial recruitment of ATM to DSBs, but for the stable association of activated ATM with 
the damaged chromatin (So et al., 2009). The regulation of ATM autophosphorylation is 
under the control of three serine/threonine phosphatases, PP2A, PP5 and Wip1, so that 
ATM is not activated in an untimely manner in the absence of DSBs. Interestingly, defects in 
the activity of these phosphatases also lead to disease phenotypes in knock-out mice (Peng 
and Maller, 2010). 
3.7.2 Amplification of the signal 
Activated ATM rapidly phosphorylates and activates several DNA repair factors to directly 
promote their recruitment to sites of DNA damage. Perhaps, the most important event is the 
ATM-dependent phosphorylation of the histone variant, H2AX at the C-terminal of the 
protein, corresponding to Ser139 (γ-H2AX) (Rogakou et al., 1998). Remarkably, in 
mammalian cells, this phosphorylation spreads over a 2 Mb domain of chromatin 
surrounding the DSB. γ-H2AX flanked DSB creates a specialized chromatin compartment 
capable of recruiting and retaining DNA repair factors. Indeed, mice deficient for H2AX 
develop genomic instability and cancers (Celeste et al., 2002). A large number of proteins 
have been identified as substrates for activated ATM and this list includes the proteins 
SMC1, NBS1, CHK2, p53, BRCA1 and MDC1 (Harper and Elledge, 2007). Key amongst these 
substrates are the Chk2 kinase and p53 which act to reduce cyclin-dependent kinase (CDK) 
activity. The direct consequence of reduced Cdk activity is that cells arrest in the various 
stages of cell cycle to allow time of the completion of DNA repair. Amongst the various 
ATM substrates, MDC1, in particular, is an important mediator of DSB signalling because it 
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recognizes and binds γ-H2AX via its tandem BRCA1 C-terminal (BRCT) domains. The 
MDC1 C-terminal domain has been crystallized with γ-H2AX and the importance of this 
interaction was shown by experiments where mutations either in the phospho-acceptor site 
or in the conserved residues of BRCT domain impaired repair foci recruitment after DSB 
induction. Moreover, accumulation of several other repair factors such as NBS1, 53BP1 and 
the phosphorylation of ATM were reduced when MDC1-γ-H2AX interaction was abrogated. 
The serine-aspartic acid-threonine (SDT) repeats near the N-terminus of MDC1 are 
phosphorylated by Casein kinase 2, and this enables the interaction of MDC1 with NBS1. 
This interaction is not controlled by DNA damage, and MDC1 and MRN already exist as a 
complex in undamaged cells. Upon the generation of γ-H2AX, MDC1 together with MRN is 
recruited via the BRCT domain of MDC1. The concentrated binding of ATM to MDC1 and 
MRN further promotes the phosphorylation of H2AX, resulting in the amplification of the 
DDR. Thus, MDC1 is an important mediator of the DDR that regulates both the recruitment 
and retention of several downstream proteins (Huen and Chen, 2010).  
Elegant work from the Misteli laboratory has established that the stable tethering of MDC1, 
MRN or ATM to DNA is sufficient to induce the DDR, even in the absence of DSBs. Upon 
targeted binding of MRN to a repetitive array, MDC1 and 53BP1 were recruited in an 
H2AX-dependent manner (Soutoglou and Misteli, 2008).  These and other studies have 
given rise to the current model that MRN binding causes ATM recruitment and activation 
which initiates γ-H2AX formation. When MDC1 interacts with γ-H2AX, it provides a 
platform for the recruitment of MRN and ATM resulting in further propagation and 
spreading of γ-H2AX. Interestingly, when the kinetics of recruitment of DDR factors to DSBs 
was studied by live-cell imaging, NBS1 and MDC1 were the first factors to get recruited, 
seconds after DSB induction. The appearance of 53BP1 and BRCA1 was significantly slower 
that the MDC1 and NBS1 and more significantly, 53BP1 and Brca1 recruitment were 
abolished in MDC-null cells. This gave rise to a hierarchical model that the recruitment of 
53BP1 and Brca1 was dependent on the stable recruitment of MDC1 through its interaction 
with γ-H2AX (Bekker-Jensen et al., 2006).  
3.7.3 Recruitment of 53BP1 and Brca1 
How exactly are Brca1 and 53BP1 recruited to DSB sites? A flurry of papers in recent years 
solved this conundrum through the identification of a ubiquitination cascade at DSB lesions. 
The product of the tumor suppressor gene BRCA1 plays a central role in the maintenance of 
genomic integrity. Brca1 has been shown to regulate several cellular processes including 
transcriptional regulation, centrosome duplication, HR, NHEJ and checkpoint control. 
BRCA1 encodes a large protein of 1863 amino acids and contains tandem BRCT domains in 
its C-terminal region (Huen et al., 2010). In its N-terminus, it harbours a RING finger 
domain that specifically interacts with the structurally related protein Bard1 (BRCA1-
associated ring domain protein 1) to heterodimerize and form a functional E3 ubiquitin 
ligase which forms a complex with E2 UBCH5C to promote the formation of K6-linked 
ubiquitin chains, an unusual chain linkage. The Brca1-Bard1 heterodimer form three non-
overlapping complexes with distinct functions. The complexes are formed between Brca1 
and phosphorylated proteins through the BRCT domain. The complexes include Brca1-
BRIP, Brca1-CtIP and Brca1-Abraxas-Rap80-BRCC36 complexes. The Brca1-Abraxas-Rap80 
complex mainly accumulates at DSBs and promotes the G2/M checkpoint. BRCC36 is a 
deubiquitinating enzyme and it is speculated that it might regulate Brca1-Bard1 
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ubquitination activity.  The key mediator of Brca1 recruitment to DSB sites is Rap80. It was 
found that Rap80 depletion abolished Brca1 focus formation, whereas Brca1 depletion did 
not affect Rap80 focus formation. This strongly suggested that Rap80 controlled Brca1 focus 
formation. Upon mapping the site required for focus formation, it was found that the UIM 
motifs of Rap80 are required. The ubiquitin-binding function of the UIM motif is important 
to facilitate BRCA1-Rap80 recruitment to DNA lesions and the introduction of mutations 
that reduce ubiquitin binding also impair Brca1 and Rap80 focus formation. These studies 
led to the idea that a ubiquitin-dependent signalling system is important for Brca1 
recruitment to sites of DSBs (Al-Hakim et al., 2010). 
An important breakthrough in this area of research was made upon the identification of 
RNF8, the first of the three E3 ubiquitin ligases that catalyze regulatory ubiquitination at 
DNA lesions (Mailand et al., 2007). Importantly, the ubiquitin ligase activity of RNF8 was 
found to be absolutely essential for the recruitment of both Brca1 and 53BP1 to DSBs.  RNF8 
contains an FHA domain at its N-terminus and a RING finger motif at its C-terminus. The 
FHA domain of RNF8 recognises the ATM phosphorylated site of MDC1, leading to its 
recruitment to IRIF. The FHA domain of RNF8 also interacts with the HECT domain of the 
second E3 ligase HERC2, thus recruiting HERC2 to DSB sites. RNF8 together with HERC2 
facilitates the assembly of the E2 ubiquitin conjugating enzyme Ubc13 to initiate K63-linked 
ubiquitin chains on H2A and its variants. The third E3 RING domain ubiquitin E3 ligase 
RNF168 recognizes and binds to K63-linked ubiquitin chains on H2A and H2AX through its 
two MIUs ((Motif Interacting with Ubiquitin). This amplifies the local concentration of K63-
linked ubiquitin resulting in the recruitment and retention of 53BP1 and BRCA1 at the sites 
of lesions. Interestingly RNF168 was first identified as the gene mutated in RIDDLE 
syndrome (Stewart et al., 2009). RIDDLE (Radiosensitivity, immunodeficiency, dysmorphic 
features and learning difficulties) is a novel human immunodeficiency disorder associated 
with defects in DSB repair and Brca1/53BP1 recruitment defects. 
Recently, another layer of complexity has emerged in the scenario of post translational 
modifications occurring following DSB induction. DSB-induced ubiquitylation and the 
recruitment of BRCA1 and other repair proteins to the sites of damage are also regulated by 
SUMOylation, placing SUMOylation as a critical post-translational modification necessary 
for optimal ubiquitylation at DSBs (Tang and Greenberg, 2010). Apart of ubiquitination and 
sumoylation, methylation of histones is also important for 53BP1 recruitment. According to 
a recent study, the loading of 53BP1 to DNA lesions is enabled by a local increase in H4K20 
dimethylation surrounding the DSBs and this step is catalysed by the histone 
methyltransferase MMSET (Pei et al., 2011). 
3.8 Coordinating DDR with cell cycle transitions 
One important cellular consequence of DNA damage is the activation of cell cycle 
checkpoints which are surveillance mechanisms that arrest the cell cycle until repair is 
satisfactorily accomplished. The cell cycle is regulated through oscillations in cyclin 
dependent kinase activity (CDK) whose activity is upregulated by cyclins and inhibited by 
cyclin-dependent kinase inhibitors (CKI) and inhibitory phosphorylation of CDKs 
(Guardavaccaro and Pagano, 2006). At the molecular level, the DNA damage checkpoint 
arrests cell cycle transitions by directly reducing CDK activity through various mechanisms 
mainly initiated by ATM and ATR.  Two ATM-dependent G/S checkpoints have been 
described. ATM activation by DSBs in G1 leads to Chk2 phosphorylation and consequent 
phosphorylation of the phosphatase CDC25A.  This results in the formation of a 
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phosphodegron which marks CDC25A for ubiquitin-mediated degradation and prevents 
the Thr14/Tyr15 dephosphorylation-mediated activation of CDK2. A second mechanism 
underlying the G1/S checkpoint involves the phosphorylation and stabilization of p53, 
either directly by ATM or indirectly by Chk2, which in turn acts as the transcription factor 
for the CKI, p21. This results in delayed G1/S transition after DNA damage. Together, 
CDC25A degradation and p21 upregulation form the basis for G1/S checkpoint 
maintenance (Bartek and Lukas, 2007). 
During the S phase checkpoint, ATR is activated in response to stalled replication forks 
leading to the phosphorylation of Chk1 and the subsequent phosphorylation mediated 
degradation of Cdc25A by the SCF (Skp1-Cullin-F-box) β-TRCP ubiquitin ligase 
(Guardavaccaro and Pagano, 2006). This causes the inhibition of CDK2-Cyclin E/A activity 
preventing the initiation of new replication origins to slow down DNA replication.  The 
failure to regulate Cdc25 leads to hyperactive Cdk activity and defective intra-S phase 
checkpoint.  Yet another regulatory circuit to prevent DNA replication during repair 
involves the targeted degradation of Cdt1 which loads the replicative helicases MCM2-7 to 
form the pre-replication complex (Arias and Walter, 2007). 
The G2/M checkpoint is initiated by the phosphorylation of checkpoint kinases, Chk1 and 
Chk2, which phosphorylate and inactivate CDC25C phosphatase by promoting its 
inhibitory sequestration by 14-3-3 proteins. This prevents the dephosphorylation-mediated 
activation of CDK1-Cyclin B complex required for mitotic progression (Lukas et al., 2004). 
Another target of the G2/M checkpoint are the Wee1 kinases. During a normal G2/M 
transition, Polo kinase 1(Plk1) phosphorylates Wee1 to create a phosphodegron that targets 
Wee1 for ubiquitin-mediated proteolysis. In the wake of G2/M checkpoint activation, Plk1 
is negatively regulated by ATM/ATR and Wee1 accumulates in the cell to maintain CDKs in 
their inhibited form.  Together, these mechanisms act in concert to halt cell cycle progression 
until the completion of DNA repair (Harper and Elledge, 2007). 
3.9 Identification of novel ATM/ATR substrates using proteomic approaches 
Recently, it has become apparent that DNA damage-activated kinases do not simply contact 
key individual proteins in a process, but phosphorylate multiple proteins of individual 
pathways. Importantly, understanding such linkages could have tremendous implications 
for human disease. In a large scale proteomic study, about 900 phosphorylation sites 
containing a consensus ATM and ATR phosphorylation motif were identified in 700 
substrates that were inducibly phosphorylated after irradiation (Matsuoka et al., 2007). 
Based on the rationale that ATM and ATR phosphorylate substrates at the consensus 
SQ/TQ motifs, a phospho-antibody specific directed against this consensus site was used to 
immunoprecipitate peptides and mass spectrometric analyses was performed. The 
identified proteins were clustered into modules based on their known function.  Multiple 
modules involved in DNA replication were identified such as the Orc module consisting of 
Orc3 and Or6, MCM module, including Mcm2, Mcm3, Mcm6, Mcm7 and Mcm10, RFC 
clamp-loader module consisting of Rfc1 and Rfc3 and the DNA polymerase module 
composed of the catalytic subunit of DNA polymerase epsilon, its interacting protein PolE4 
and two translesion polymerases PolL and PolQ. Other modules included the mismatch 
repair module consisting of the proteins, Msh2, Msh3 and Msh6 and Exo1, excision repair 
module included XPA, XPC, RPA1, CSB, components of the transcription factor IIH, a 
fanconi anaemia module and a HR module. Interestingly, three components of the COP9 
signalosome involved in the regulation of SCF (Skp1-Cullin-F-box) E3 ligase function and a 
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novel cell cycle module comprising Cyclin E and its negative regulators FBW7, p27kip1 and 
CIZ1 were also identified as ATM/ATR substrates.  Other proteins included components 
of the spindle checkpoint pathway comprising of Bub1, Mad1, Sgo1 and Mad2BP, Cdc26, 
separase, and cohesion subunits SMC1 and SMC3. Perhaps, the most interesting group of 
substrates were proteins in the insulin−IGF-1 (insulin-like growth factor)−PI3K 
(phosphatidylinositol 3-kinase)−AKT pathway, including the adaptor molecule IRS2 
(insulin receptor substrate 2), the kinase AKT3, two regulators of AKT, HSP90 (heat shock 
protein 90), and PP2A (protein phosphatase 2A), and several downstream effectors of 
AKT such as FOXO1, and proteins involved in translation control such as TSC1 (tuberous 
sclerosis 1), 4E-BP1 (eIF4E binding protein 1), and p70S6K (ribosomal protein S6 kinase). 
This indicates that the DDR is likely to control the insulin-IGF pathway in multiple ways 
and further studies in this direction will shed light on the role of ATM/ATR pathway in 
human metabolic syndromes such as diabetes and other age-associated metabolic 
disorders. 
4. Physiological roles of DDR 
It has now become apparent that the DDR pathway is not just activated in response to 
genotoxic stress, but that it is essential for several physiological processes. Examples where 
genome alterations are induced in a programmed manner are V(D)J recombination (Bassing 
and Alt, 2004), class switch recombination (CSR) (Stavnezer et al., 2008) and somatic 
hypermutation (SHM) (Di Noia and Neuberger, 2007). These processes occur in developing 
T and B lymphocytes to generate T-cell receptor and immunoglobulin diversity, to allow the 
recognition of pathogens (Jackson and Bartek, 2009).  In the meiotic cells, the DDR plays an 
important role when homologous chromosomes align and exchange genetic information by 
recombination.  Meiotic HR is generated by the topoisomerase II-like enzyme Spo11, which 
generates DSBs. In subsequent steps that require MRN complex, HR recombination occurs 
which requires all mitotic HR proteins along with a Rad51-like protein, DMC (Richardson et 
al., 2004).  In the developing nervous system, high levels of oxidative and metabolic stress 
are effectively repaired by the DDR.  During infections with pathogens such as the avian 
influenza virus, the DDR proteins modulate the virulence properties of the virus through 
recombination (Jackson and Bartek, 2009). During bacterial infections, bacterial pathogens 
with defects in MMR, termed mutators or hypermutators, are overrepresented and are 
hypothesized to be advantageous for the establishment of chronic infections (Sundin and 
Weigand, 2007). DDR proteins also play important roles at normal telomeres and thus their 
defects cause telomere shortening and/or telomere dysfunction associated with 
chromosome fusions and instability (Jackson and Bartek, 2009). Telomeres are recognized by 
DDR proteins such as Mre11 (DSB repair), XPF/Ercc1 (NER), Ku70/Ku80 (NHEJ repair), 
Bloom and WRN RecQ helicases and Rad51D (HR repair) (Denchi, 2009).  These factors are 
recruited to the telomeres through their direct interaction with protein of the shelterin 
complex, a complex of six telomere binding proteins that promote telomere homeostasis. 
Recent studies have also established a relationship between DDR and another physiological 
phenomenon, the circadian rhythm, a process controlled by light stimuli (Sancar et al., 2010). 
The circadian rhythm regulator clk-2 has been shown to affect radiation sensitivity in 
C.elegans and S phase checkpoint in response to replication stress in mammalian cells.  NER 
has also been shown to be regulated by the circadian clock and there is strong evidence that 
the clock protein Cry participates in the maintenance of genomic integrity against DNA 
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damage induced by UV and UV mimetics. It has been proposed that such linkages between 
light cycle and DNA repair can allow cells to respond appropriately to environmentally-
induced DNA damage ((Jackson and Bartek, 2009)). Described in greater detail below are 
the physiological roles of DDR in the immune system, meiosis and in the maintenance of 
genome integrity of stem cells. 
4.1 V(D)J recombination and class switch recombination 
One of the cell types where programmed DSBs are generated are B and T lymphocytes. B 
and T cells are the main components of the adaptive immune system and responsible for the 
generation of B cell receptors (BCRs, also known as immunoglobulins) and T cell receptors 
(TCRs), which together recognize a large repertoire of antigens. During the development of 
antigen receptor genes, a large number of variable (V), diversity (D), joining (J) and constant 
(C) segments undergo rearrangement by processes termed as V(D)J recombination and class 
switch recombination (CSR) (Bassing and Alt, 2004; Stavnezer et al., 2008). Immunoglobulin 
(Ig) contains a heavy chain and either a ǋ or ǌ light chain. TCRs are composed of either αǃ or 
Ǆǅ dimers. In humans, Ig heavy chain loci contain 51 VH, 27 DH, 6 JH and 9 CH segments and 
Ig light chain loci contain 40 Vǋ, 31 Vǌ, 5 Jǋ and 4 Jǌ segments; TCR loci consist of 54 Vα, 61 
Jα, 67 Vǃ, 14 Jǃ, 2 Dǃ, 14 VǄ, 5 JǄ, 3 Vǅ, 3 Jǅ and 3 Dǅ segments. Roughly, 107 Igs and TCRs 
can be generated by V(D)J recombination. In response to antigens, antigen receptors are 
further diversified by CSR and somatic hypermutation (SHM). In the following section, 
V(D)J recombination and CSR during B cell development will be reviewed. 
B cell development begins in the fetal liver during development and continues in the bone 
marrow shortly after birth. It is a highly ordered process, mediated by cytokines secreted by 
bone marrow stromal cells and lineage-specific transcription factors. In response to 
cytokines such as IL-7, common lymphoid progenitors are committed to B cell lineage. 
Subsequently, cells undergo DH-JH joining at the Ig heavy chain locus and begin expressing 
CD45 (B220) and class II MHC (major histocompatibility complex), which is followed by the 
joining of a V segment to the completed DJH. After successful V(D)J recombination, pro-B 
cells become pre-B cells, which undergo V-J joining on one L chain locus and further 
develop into mature B cells. V(D)J recombination is regulated at three levels: chromatin 
remodelling, DSB generation mediated by lymphoid-specific recombinases (Rag-1/2) and 
recombination via NHEJ and microhomology-mediated end joining (MMEJ, also called 
alternative NHEJ) machinery. 
In eukaryotic cells, DNA is wrapped into a compact chromatic structure, which needs to be 
‘opened’ to allow accessibility for further processing. Increasing evidence in genetically 
modified mouse models shows that covalent histone modifications, such as methylation on 
histone H3 at lysines 4, 9 and 27  (K4, K9 and K27) positions, mediate chromatin 
remodelling and subsequently V(D)J recombination. Enhancer of Zeste 2 (Ezh2) is a 
methyltransferase which trimethylates K27 of histone H3 (H3K27me3). Conditional deletion 
of Ezh2 in B lymphocytes leads to reduced H3K27me3 levels and defective VH-DJH 
recombination at the most distal V segments (Su et al., 2003). Di- and tri-methylation of 
histone H3K4 are also found to be associated with the active segments in V(D)J 
recombination (Liu et al., 2007). Rag-2 binds to H3K4me3 via the PHD motif and mutations 
that abolish the interaction impair V(D)J recombination. In contrast, H3K9me2, a silent 
chromatin mark, inhibits distal VH-DJH recombination (Osipovich et al., 2004), while Pax5, a 
transcriptional factor required for early B cell commitment, regulates the removal of 
H3K9me2 and promotes VH-DJH recombination (Johnson et al., 2004). 
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The coding sequences of IgH are separated by recombination signal sequences (RSSs). RSSs 
are conserved heptamers (CACTGTG) and nonamers (GGTTTTTGT) flanking either 12 base 
pairs (bp) or 23±1 bp non-conserved DNA, called the spacer. The recombination of DH to  
JH, VL to JL or VH to DJH occurs only between the 12 bp- and 23 bp-spacers, known as  
12/23 spacer rule. Rag-1 and Rag-2 recognize RSSs and generate DSBs between the 
heptamers and its adjacent coding segment. Rag-1/2 first introduces a nick on one strand 
and then the nicked free coding end attacks the opposite strand, creating a closed hairpin 
structure. Disruption of either Rag-1 or Rag-2 in mice causes severely impaired V(D)J 
recombination, defective B cell development and immunodeficiency (Mombaerts et al., 1992; 
Shinkai et al., 1992). 
The final step of V(D)J recombination involves NHEJ and MMEJ machineries where the two 
coding segments are ligated together. The proteins involved in NHEJ are not all known and 
new proteins are constantly being uncovered. Here, in this section we discuss those that are 
well-studied, including DNA-PK, Artemis endonuclease, and XLF (Xrcc4-like factor, also 
known as Cernunnos)-Xrcc4-DNA ligase IV complex. Deficiency in any of these proteins 
compromises B and/or T cell development. DNA-PK consists of catalytic subunit DNA-
PKcs and regulatory subunits Ku70 and Ku80. As mentioned earlier, DNA-PKcs 
phosphorylates H2AX at DSB to transduce signalling, while Ku70 and Ku80 form a 
heterodimer to process the broken ends. DNA-PKcs deficiency is the main cause of murine 
severe combined immunodeficiency (SCID), where both B and T cells are depleted (Blunt et 
al., 1995). Any defects in Ku protein also impair V(D)J recombination (Gu et al., 1997; 
Taccioli et al., 1993). Artemis is thought to open the closed hairpin at the coding ends 
generated by Rag-1/2. Null mutants of Artemis also give rise to the severe combined 
immunodeficiency (SCID) phenotype (Li et al., 2005). Xrcc4 together with XLF and DNA 
ligase IV ligates the broken ends together. Cells deficient for either Xrcc4, XLF or DNA 
ligase IV are sensitive to Ǆ-irradiation and compromised in V(D)J recombination (Ahnesorg 
et al., 2006; Gao et al., 1998). 
Upon antigen or humoral stimulation, CSR further diversifies antibodies by switching their 
isotypes. Human BCR heavy chain gene contains 9 CH segments: 1 Ǎ (IgM), 1 ǅ (IgD), 4 Ǆ 
(IgG), 1 ǆ (IgE) and 2 α (IgA). CSR occurs between two switch (S) regions located upstream 
of each CH segment, except for Cǅ; the switch between CǍ (IgM) and Cǅ (IgD) is achieved by 
alternate splicing before complete maturation of B cells. Similar to V(D)J recombination, CSR 
also involves DSB generation and NHEJ. DSBs are created by dC deamination, BER and 
MMR machinery within or near S regions. In response to humoral stimulation, activation-
induced cytidine deaminase (AID) deaminates dC resulting in dU bases on both strands of 
two transcriptionally active S regions (Chaudhuri et al., 2003). The dU is excised by the 
uracil DNA glycosylases (UNG) and the resultant abasic site is further cut by 
apurinic/apyrimidinic endonuclease 1/2 (APE-1/2), generating SSBs. Either two adjacent 
SSBs on opposite strands spontaneously lead to one DSB, or the MMR machinery is 
triggered to convert SSB to DSB (Schrader et al., 2007). Deficiency of AID, UNG, APE  or any 
of the MMR components, including Msh2, Msh6, Mlh1, Pms2 and Exo1, leads to  loss or 
reduction of CSR in B cells (Stavnezer et al., 2008). After DSB formation, NHEJ rather than 
HR pathway is activated. Components of classical NHEJ (C-NHEJ) pathway are important 
but not essential for CSR in B cells. Ku70-Ku80 heterodimers bind to the DNA ends and 
recruit necessary proteins to process the DNA ends to facilitate the ligation mediated by 
Xrcc4-DNA ligase IV complex (Nick McElhinny et al., 2000). CSR in Ku70−/− and Ku80−/− B 
cells is nearly ablated (Casellas et al., 1998; Manis et al., 1998). Either Xrcc4 or DNA ligase IV 
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deficiency causes significant reduction in CSR (Soulas-Sprauel et al., 2007; Yan et al., 2007). 
While compatible ends are joined rapidly by canonical NHEJ components, complex lesions 
need substantial processing and are re-ligated slowly. In the later case, ATM, 53BP1 and 
MRM complex cooperate with canonical NHEJ components to mediate end-joining 
recombination. Disruption of ATM (Bredemeyer et al., 2006; Reina-San-Martin et al., 2004), 
53BP1 (Manis et al., 2004) or MRN complex (Kracker et al., 2005) in mice leads to defects in 
either V(D)J recombination or CSR or both. Recent studies in mouse models deficient for 
NHEJ core components revealed a robust alternative NHEJ pathway (A-NHEJ) that utilizes 
microhomology to mediate the end joining in CSR (Soulas-Sprauel et al., 2007; Yan et al., 
2007). A-NHEJ leads to Ig locus deletion and translocation. The molecular mechanisms 
underlying A-NHEJ are not well elucidated so far. 
4.2 Meiosis 
Meiosis is a form of cell division occurring in sexually reproducing organisms by which 
maternal and paternal chromosomes are distributed between cells to generate genetic 
diversity. Prior to meiosis, each chromosome duplicates and creates two sister chromatids, 
which stay connected at the centromere. During meiosis, the homologous chromosomes 
align in parallel and chromosomal crossovers are induced by recombination. DSBs are 
generated by meiosis-specific topoisomerase-like enzyme Spo11 (Keeney et al., 1997), 
together with Mei1. Mice lacking Spo11 or Mei1 fail in the generation of DSBs, leading to 
absence of Rad51 foci, faulty synapsis, meiotic failure and eventually infertility (Baudat et 
al., 2000; Libby et al., 2003; Munroe et al., 2000; Romanienko and Camerini-Otero, 2000). The 
generation of DSB on meiotic chromosomes is not entirely random but occurs preferentially 
on specific chromosomal locations, known as hot spots. Recombination regulator 1 (RCR1) 
and double strand break control 1 (DSBC1) regulate the activities of recombination hot spots 
(Grey et al., 2009; Parvanov et al., 2009). Although the molecular mechanisms underlying 
the selection of hot spots for DSB induction are still under investigation, it has been found 
that high-order chromatin structure could be an important factor (Buard et al., 2009). Of 
particular interest is the methylation of histone H3K4me3 by the methyltransferase Prdm9 
(also known as Meisetz), which is enriched at meiotic recombination hot spots (Baudat et al., 
2010; Borde et al., 2009; Buard et al., 2009). Prdm9 null mice are sterile owing to defective 
chromosome paring and impaired sex body formation (Hayashi et al., 2005; Mihola et al., 
2009). 
Many components of the HR pathway are of particular importance for proper strand 
exchange and meiosis. As mentioned earlier, MRN complex is recruited to the DSBs to 
remove Spo11 and degrade the 5’ of DNA, generating long 3’ ssDNA overhangs. ATM is 
activated by MRN and further amplifies the signaling via phosphorylation of many 
downstream transducers and effectors, such as H2AX and Chk2 (Shiloh, 2003). Finally, 
ubiquitously expressed Rad51 and meiosis-specific Dmc1 recognize and bind to the resected 
3’ ssDNA overhangs and form nucleoprotein filaments, which mediate the search for 
homologous template and subsequent strand exchange. As they are all essential for 
development, disruption of either Rad51 or any component of MRN complex causes 
embryonic lethality (Buis et al., 2008; Luo et al., 1999; Zhu et al., 2001). Loss of ATM in mice 
causes general defects in DSB repair and mislocalization of Rad51 and Dmc1 in 
spermatocytes (Barlow et al., 1996; Barlow et al., 1998). During meiosis, Dmc1−/− germ cells 
arrest at the early zygotene stage due to the failure of homologous chromosome synapsis 
(Yoshida et al., 1998).  
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In contrast to mitotic recombination in which Rad51-mediated HR utilizes the identical 
sister chromatid as homologous template (reviewed earlier in Section 2.6), Rad51 and Dmc1-
mediated strand invasion prefers the chromatids from the homologous chromosome in 
meiotic recombination. This preference is achieved with the help of other factors such as 
chromosome-associated kinase Mek1, which excludes identical sister chromatid from being 
selected as a homologous template for further meiotic recombination. As a byproduct, this 
generates a heteroduplex DNA (hDNA) if there are heterologies between the two 
homologous chromosomes (maternal and paternal). In this case, MMR pathway is activated 
to repair the hDNA, resulting in either gene conversion (GC) or restoration of original 
sequences (Kramer et al., 1989). Two recombination pathways are employed, i.e. cross-over 
(CO) and non-cross-over (NCO). CO occurs when double Holiday junctions (dHJs), which 
are visualized as chiasmata, are formed and subsequently cut by resolvases. NCO is also 
known as synthesis-dependent strand annealing (SDSA), leading to gene conversion. MMR 
pathways are not only restricted to resolving hDNA because Mlh1−/− mice exhibit defective 
gametogenesis due to reduction of chiasmata, recombination and COs, and deficiency in 
Pms2 leads to disrupted synapsis (Baker et al., 1995; Baker et al., 1996; Edelmann et al., 1996). 
Msh4 and Msh5 are two meiosis-specific homologues of MutS, which interact with Rad51 to 
stabilize the synaptonemal complex (SC) mediated chromosome paring. Targeted mutations 
of Msh4 and Msh5 in mice give rise to meiotic-specific phenotypes, including meiotic arrest 
at zygotene stage and defective synapsis (de Vries et al., 1999; Edelmann et al., 1999; Kneitz 
et al., 2000). Mlh3 and Exo1 null mice are also infertile, attributed to meiotic failure and 
apoptosis (Lipkin et al., 2002; Wei et al., 2003). 
4.3 DNA damage signaling in stem cells 
Recently, it has become apparent that tissue stem cells possess an elaborate DDR to maintain 
organ homeostasis, although the mechanistic details seem to vary greatly between different 
tissues. The DDR in response to radiation exposure has been studied in detail in at least four 
adult stem cell types: epidermal stem cells, hematopoietic stem cells, mammary stem cells 
and intestinal stem cells. By comparing the response of haematopoietic stem cells (HSCs) 
with their differentiated progeny at low doses of IR, it has become clear that different DNA 
repair and signalling mechanisms exist within the stem cell compartment.  Using fetal 
human umbilical cord blood derived HSCs and by comparing them with their more mature 
progenitors, it was found that stem cells had greater level of apoptosis, due to the ASPP1 
protein, and the phenotype could be rescued by the down regulation of p53 (Milyavsky et 
al., 2010). In contrast, when a similar experiment was performed using adult mouse HSCs, 
low doses of IR showed a greater degree of protection in stem cells as compared to their 
differentiated counterparts. The underlying mechanism was proposed to be the increased 
expression of anti-apoptotic Bcl2, Bcl-xl which inhibited p53-mediated cell death, while 
allowing p53-dependent increase in p21 expression (Mohrin et al., 2010). Interestingly, 
quiescent HSCs mostly preferred NHEJ pathway for DNA repair, and as a consequence 
their progeny often showed increased levels of genomic instability due to misrepaired DNA. 
Recent investigations using multipotent hair follicle bulge stem cells (BSC) also revealed that 
BSCs were more resistant to DNA damage-induced cell death as compared to other cells of 
the epidermis (Blanpain and Fuchs, 2009). The underlying mechanism was shown to be the 
increased expression levels of anti-apoptotic Bcl2 and the transient and reduced duration of 
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p53 up regulation. BSCs also displayed accelerated repair by the error-prone NHEJ pathway 
and this result suggested that both HSCs and BSCs show short term survival in the wake of 
DNA damage at the expense of a compromise on their genomic integrity. 
Irradiation experiments have also been performed on intestinal stem cells (ISC) to 
understand their DDR.  The intestinal stem cells are localized at the bottom of the crypt, 
where they proliferate and generate the transit amplifying cells, which divide and migrate 
to the upper part of the crypt. At least two distinct stem cell populations have been isolated 
from the intestine corresponding to the +4 position from the bottom of the crypt, which are 
positive for the stem cell marker Bmi1+ and quiescent and the cycling Lgr5+ fraction located 
in between the paneth cells at the base of the intestinal crypt (Barker et al., 2010). Radiation 
sensitivity experiments have revealed that the quiescent stem cells at the +4 position are 
extremely radiosensitive, followed by the more active Lgr5+ve cells, whereas the rapidly 
cycling transit amplifying cells were the most radioresistant.  Different mechanisms have 
been proposed for the extreme sensitivity of the Bmi1+ve ISCs to DNA damage, such as 
enhanced activation of the p53 pathway, lower expression of anti-apoptotic protein Bcl2. 
However, based on the observation that IR-induced stem cell apoptosis is blocked in 
PUMA-deficient mice, it is accepted that Puma is the main mediator of DDR in ISCs (Qiu et 
al., 2008). The DDR has also been studied in germ stem cells (GSC) since the inability to 
repair DNA damage in the germ line can be extremely dangerous and can directly lead to 
infertility or the transmission of genetic diseases. The main source of DNA damage in the 
germ-line could be from teratogenic chemicals or from normal metabolic activity and ROS 
production. In studies using human male GSCs, it was found that these cells are mostly kept 
in the G0/G1 phase of the cell cycle, and preferentially use NHEJ as their repair of choice. 
On the other hand, the female GSCs are located in the oogonia where the homologous 
chromosomes are close to each other and hence HR is the preferred pathway for DNA repair 
(Forand et al., 2009). Interestingly, in contrast to other stem cell populations, the female 
GSCs do not depend on p53 for their genomic integrity. Instead, TAp63, an isoform of the 
p63 gene, is constitutively expressed in oocytes and is the primary mediator of DDR. 
Consistently, TAp63 deletion in mice results in an increase in oocyte radioresistance (Suh et 
al., 2006). The study of DNA repair in another stem cell type, namely the mammary stem 
cells (MSCs), is clinically very relevant because, mutations in Brca1 and Brca2 are found in a 
majority of patients with hereditary breast cancers, demonstrating the importance of HR in 
preventing the onset of mammary tumors. The MSCs are responsible for the homeostasis of 
the breast tissue, and represent multipotent stem cells that self-renew and differentiate into 
the various lineages. Mouse MSCs are more radioresistant than their differentiated progeny. 
MSCs present less DNA damage and following IR exposure, activate the Wnt/beta-catenin 
pathway and increase the survival of MSCs through the upregulation of survivin, a direct 
Wnt target gene (Woodward et al., 2007). 
5. DNA damage response and human diseases 
Congenital or acquired defects in genes involved in the DDR give rise to disease phenotypes 
such as neurodegeneration, infertility, immune deficiencies, growth retardation, cancer and 
premature aging. In the following sections, human diseases caused due to impaired DDR 
are described in greater detail and summarized in Figure 3 and Table 1. 
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Fig. 3. Physiological roles of DDR and disease phenotypes caused by defective DNA repair 
5.1 Neurodegeneration 
The mammalian nervous system is generated through consecutive cycles of proliferation, 
differentiation and maturation that eventually give rise to the various cell types of the brain.  
Two main classes of cells make up the nervous system: the glia and the neurons, and these 
contain many specialized sub-types.  These cells exit the cell cycle, migrate and differentiate 
to form the nervous system.  In general, neurons display high rates of transcription and 
translation which are associated with high rates of mitochondrial and metabolic activity. 
Thus, the neural cells are more susceptible to DNA damage than other adult tissue cell types 
because they face high levels of oxidative and metabolic stress during their life time. The 
DNA damage takes the form of both SSBs and DSBs that have to be efficiently repaired to 
maintain neural homeostasis. Indeed, one of the most commonly observed symptoms in 
both DNA repair-deficient mice and in humans is that of neurodegeneration. This is mainly 
because individuals possessing mutations in DNA repair pathways are incapable of 
handling DNA damage in the neurons, resulting in neuronal cell death that is manifested as 
neurodegeneration (Katyal and McKinnon, 2008).  
The DNA strand breaks in the nervous system may arise due to reactive oxygen species (ROS) 
that arise as a by-product of cellular metabolism. ROS, in turn carries out nucleophilic attack 
on DNA to generate single strand breaks. Due to the high levels of oxygen consumption in the 
brain, ROS levels are very high in the neurons compared to other adult cell types. In fact, tens 
to thousands of SSBs are generated by ROS in neuronal cells, and these constitute the single 
largest source of DNA damage in the nervous system (Katyal and McKinnon, 2008). As 
discussed earlier (Section 3.1), SSBs are efficiently detected by PARP which recruits the 
scaffolding protein XRCC1 so that the DNA lesions can be resolved by enzymes involved in 
DNA processing. Unrepaired SSBs can cause a block in transcription, or replication forks can 
collide with SSBs resulting in DSBs that have to be then repaired by the DSB repair pathway. 
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Human monogenic neurodegenerative defects associated with DDR defects can be broadly 
classified as those associated with DSB repair or SSB repair. Defective DSB repair associated 
neuropathologies include A-T, Nijmegen breakage syndrome (NBS), ATLD (A-T like 
disorder), Seckel syndrome, Primary microcephaly (PM), and the Lig4 syndrome.  In most 
DNA repair-associated syndromes, cerebellum is often the primary target of 
neurodegeneration which then spreads to the remaining parts of the brain. A-T syndrome 
arises as a result of mutations in ATM.  Since cerebellum is mainly responsible for sensory 
motor coordination, individuals with A-T often present with profound ataxia (defective 
motor coordination) and are wheelchair-bound within the first decade of life. The DDR 
pathway in A-T strongly affects the cerebellum and widespread loss of cerebellar purkinje 
cells and granule neurons is seen in A-T brains and is later accompanied by widespread 
cerebral and spinal defects.  Additionally, A-T patients develop other neurological defects 
such as defective eye movement, speech defects (dysarthria) and non-neurological 
symptoms such as the absence or the rudimentary appearance of a thymus, 
immunodeficiency, insulin-resistant diabetes, clinical and cellular radiosensitivity, cell cycle 
checkpoint defects, chromosomal instability and predisposition to lymphoid malignancies 
(Biton et al., 2008). Because of the central role of the MRN complex in the ATM-dependent 
DDR, human syndromes caused by defects in the MRN complex have been regarded as AT-
like disorders. Very similar to AT, NBS is characterized by growth retardation, frequent 
infections, microcephaly (described below), ovarian dysgenesis (defective development), 
primary amenorrhoea and lymphoma predisposition.  However, NBS cells also appear to be 
defective in some aspects of the ATR pathway and exhibit phenotypes like microcephaly 
(described below), not usually seen in A-T patients.  Patients suffering from ATLD (A-T like 
disorder) have hypomorphic mutations of MRE11 and show neurological symptoms very 
similar to A-T such as dysarthria, oculomotor apraxia and ataxia. Interestingly, a cancer 
predisposition phenotype has not been observed with ATLD. Also, in contrast to NBS 
patients, ATLD subjects do not have microcephaly (Katyal and McKinnon, 2008). 
In addition to neurodegeneration, defective DSB repair can cause developmental defects in 
the brain, resulting in the development of a smaller brain, called microcephaly where the 
brain size is at least two standard deviations smaller than the normal brain. This phenotype 
probably arises as a result of brain cell loss due to the inability to cope with DNA damage in 
the developing brain. For example, patients harbouring germ-line mutations in ATR, suffer 
from the Seckel syndrome, an autosomal recessive disorder characterized by severe 
intrauterine growth retardation, profound microcephaly, a ‘bird-like’ facial profile, mental 
retardation and isolated skeletal abnormalities (O'Driscoll et al., 2009). Patients harbouring 
mutations in the centrosomal protein pericentrin also show pronounced microcephaly as a 
result of DNA replication fork defects and defective DNA repair. Patients bearing 
hypomorphic mutations in Lig4, the DNA ligase in the NHEJ pathway also present with 
microcephaly, developmental and growth delay, immunodeficiency and lymphoid 
malignancies. Mutation in another NHEJ protein XLF, causes a disorder called as HIM 
(Human immunodeficiency and microcephaly), primarily characterised by growth delay, 
recurrent infections, autoimmunity and microcephaly (Katyal and McKinnon, 2008). 
Unlike defective DSB pathway, where the associated defects are more wide spread across 
tissues, defective SSB repair pathway often results in phenotypes restricted to the nervous 
system. For example, defective SSB repair pathway result in spinocerebellar ataxia and 
axonal neuropathy (SCAN1) and ataxia with oculomotor apraxia (AOA1), which are caused 
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by  mutations in the 3’-endprocessing enzyme tyrosyl DNA phosphodiesterase 1 (TDP1) 
and the 5’-end-processing enzyme aprataxin (APTX), respectively (McKinnon, 2009).  As 
mentioned earlier, TDP1 is an enzyme involved in the processing of damaged DNA ends, 
such as 3’-phosphoglycolate and 3’ Top1 and other non-ligatable termini generated after 
DNA oxidation, DNA replication and other types of genotoxic stress. APTX, on the other 
hand, is a nucleotide hydrolase that cleaves the 5’ adenylate intermediate prior to sealing the 
nick after the generation of SSB. Similar to A-T patients, SCAN1 and AOA1 patients show 
ataxia, oculomotor apraxia, cerebellar atrophy and dysarthria. Cockayne’s syndrome and 
XP/CS are associated with defects in CSA, CSB, XPB, XPD and is associated with 
neurological symptoms such as microcephaly, progressive neurodegeneration, cerebral and 
cerebellar atrophy and sensorineural deafness (Weidenheim et al., 2009). In another SSR-
associated syndrome called as trichothiodystrophy (TTD), the proteins XPB, XPD, TTDA are 
found defective (Stefanini et al., 2010). This syndrome is associated with cerebral cortex 
microcephaly, hypomyelination and psychomotoric abnormalities. 
Recent studies have also highlighted the role of defective DNA repair in late-onset chronic 
neuropathologies such as Alzheimer’s disease and Parkinson’s disease.  For instance, 
decreased levels of NHEJ factor DNA-PKcs and of MRN proteins and reduced BER capacity 
has been documented in Alzheimer’s disease patients, whereas increased DNA damage 
accumulation has been observed in the substantia nigra neurons, a population of neurons 
often depleted in Parkinson’s disease patients (Katyal and McKinnon, 2008).  
5.2 Infertility 
Human infertility is primarily defined as the inability to conceive after 12 months’ 
intercourse and is often underdiagnosed (Thonneau et al., 1991). However the investigation 
of human infertility is hampered by the fact that defective meiotic recombination usually 
leads to either germ cell arrest or abnormal gametes. Some candidate genes such as PRDM9 
and MEI1 have been found to contain mutations/polymorphisms in patients suffering from 
infertility (Miyamoto et al., 2008; Sato et al., 2006). MSH4 and DMC1 mutations have also 
been found in patients suffering from testis vanishing syndrome and premature ovarian 
failure (Mandon-Pepin et al., 2002). 
5.3 Immune deficiency 
As reviewed earlier in this chapter (Section 4.1), NHEJ machinery is used for V(D)J 
recombination, CSR and SHM in order to generate antigen receptor diversity. Defects in 
DSB generation and NHEJ components usually compromise V(D)J recombination, CSR 
and/or SHM, thereby leading to primary inherited immunodeficiency. Severe combined 
immunodeficiency (SCID) is a severe form of inheritable immunodeficiency. In SCID, both B 
and T adaptive immune systems are impaired and the patients are extremely vulnerable to 
various infectious diseases. Defects in V(D)J recombination usually lead to SCID in humans 
because it is required for both B and T antigen receptor generation. During V(D)J 
recombination, RAG-1 and RAG-2 are responsible for DSB generation and mutations of 
either of them in humans are reported in some cases of SCID (Schwarz et al., 1996; Villa et 
al., 1998; Villa et al., 2001). Recently the first missense mutation of DNA-PKcs was reported 
in a human patient suffering from pronounced immunodeficiency. Strikingly, the mutation 
doesn’t affect the kinase activity of DNA-PKcs but rather compromises the activity of 
Artemis (van der Burg et al., 2009). After DSB generation, Artemis processes the hairpin 
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intermediates for end-joining. Mutations in Artermis arrest B and T cells at very early stage 
in some cases of SCID, owing to the defective V(D)J recombination (Ege et al., 2005; 
Moshous et al., 2001). Hypomorphic mutations of DNA ligase IV have been identified in 
individuals with SCID or combined immunodeficiency (CID) displaying microcephaly and 
delayed growth (Enders et al., 2006; O'Driscoll et al., 2001; Riballo et al., 1999; van der Burg 
et al., 2006). Similarly, patients with XLF mutations develop severe B-T lymphocytopenia, 
microcephaly and growth retardation (Ahnesorg et al., 2006; Buck et al., 2006). 
In addition to the essential components of V(D)J recombination, mutations in other DSB 
repair factors also cause a less profound immunodeficiency characterized by defective 
lymphocyte development and IgG CSR defects. As described earlier (Section 5.1), Ataxia 
telangiectasia (AT) is a progressive genetic disorder caused by mutated ATM and is 
characterized with cerebellar ataxia, oculocutaneous telangiectasia, growth retardation, 
infertility, immunodeficiency and increased carcinogenesis mainly lymphoid tumours 
(Chun and Gatti, 2004). In AT patients, V(D)J recombination is not affected, but both B and T 
lymphocytes are restricted and skewed by diffused oligoclonal expansions (Giovannetti et 
al., 2002). While dispensable for SHM, ATM-deficient cells are compromised in diversifying 
IgM to other classes (Reina-San-Martin et al., 2004). Immunodeficiency is also manifested in 
NBS patients who are found more susceptible to infectious diseases (Digweed and Sperling, 
2004). Similar to ATM, deficiency of either NBS1 or MRE11 doesn’t affect normal V(D)J 
recombination although CSR is impaired (Lahdesmaki et al., 2004; van Engelen et al., 2001). 
5.4 Cancer 
Loss of genomic integrity and accumulation of mutations is a fundamental property of 
cancerous cells. In that context, the DDR influences cancer progression in multiple ways, as 
discussed below. 
5.4.1 DNA repair defect and familial cancers 
The concept that cancers could be acquired by DNA repair defects was first obtained by the 
study of patients suffering from familial hereditary cancers. Xeroderma pigmentosa (XP) 
was one of the first of many human cancers discovered to be acquired due to defective DNA 
repair (Cleaver, 2005). XP patients are defective in the NER of UV-induced DNA damage 
and have a 1000-fold greater risk of developing skin cancers and a 100,000 fold greater risk 
for developing squamous cell carcinoma of the tip of the tongue when compared to the 
general population. HNPCC (Hereditary non-polyposis colon cancer, also called as Lynch 
syndrome) is another inherited cancer syndrome where patients show an increased 
susceptibility to colon cancers. While the adenoma to carcinoma progression requires 8-10 
years in the general population, this process is accelerated to 2-3 years in HNPCC patients. 
The majority of HNPCC cases result from germ-line mutations in genes encoding for the 
MMR proteins MSH2 and MLH1 (Fishel et al., 1993; Leach et al., 1993). Mutations in two 
other MMR genes MSH6 and PMS2 were also detected in a small proportion of cases. The 
resulting inability to detect and repair mismatches can lead to mutations of genes possessing 
microsatellite repeats in their sequences, causing a phenotype referred to as microsatellite 
instability. In addition to hereditary cases, MMR defects have also been detected in about 
15% of sporadic gastric, endometrial and colon tumors owing to promoter 
hypermethylation and the consequent silencing of MLH1. In many of the tumors showing 
MMR defects and microsatellite instability, it is likely that hundreds of genes are 
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concomitantly mutated and some of them such as the commonly studied type II TGF-β 
receptor may confer a proliferative advantage to incipient cancer cells and drive tumor 
progression. Another example is hereditary MYH-associated polyposis, in which biallelic 
germ-line mutations in MYH, a BER gene, result in increased GC to TA transversion and 
predisposition to colon cancer (Al-Tassan et al., 2002).  Defective DSB repair attributed to 
germ-line transmission of mutant BRCA1 and BRCA2 alleles also confer enhanced 
susceptibility to breast and ovarian cancers. It is estimated that about 70-80% of all familial 
ovarian cancers is due to germ-line transmission of BRCA1 or BRCA2 (Scully and 
Livingston, 2000). Germ-line mutations in DNA repair genes NBS1, ATM, Werner syndrome 
helicase (WRN), Bloom syndrome helicase (BLM), RecQ protein-like 4 helicase (RECQL4) has 
also been linked to increased tumor susceptibility. Mutations in p53 are present in cancer-
prone families with Li-Fraumeni syndrome (Brown et al., 2009). As discussed in section 2.5, 
mutations in 14 FANC genes have been identified in Fanconi anaemia, which is an 
autosomal recessive hereditary disorder characterized by progressive bone marrow failure, 
congenital developmental abnormalities, and early onset of cancers such as acute 
myelogenous leukemia (AML) and squamous cell carcinomas of the head and neck. 
Together, these observations support the ‘mutator hypothesis’ which postulates that 
inherited defects in DDR contribute to the ‘mutator’ phenotype and increased mutation rate 
in many malignancies which might allow tumor cell survival and proliferation. 
5.4.2 DDR and sporadic cancers 
Apart from inherited mutations in proteins involved in DNA repair, recent large scale 
genome sequencing of cancer genomes have also identified mutational inactivation of 
components of the DDR machinery in sporadic cancers. Of these, mutations that perturb p53 
functions, often in its DNA binding domain, or defects in p53’s upstream or downstream 
regulatory network have been identified in more than half of all human cancer samples. 
Recently, coding sequences of about 20,000 genes in carcinomas of the colon, breast, 
pancreas and glioblastomas were sequenced. In these sequencing studies representing 68 
cancers in the discovery screen and 221 cancers in the follow-up validation screen, one of the 
most frequently mutated gene was Cockayne syndrome B (CSB), found mutated in 6 cancers 
(Sequencing data compiled by Negrini et al, 2010 (Negrini et al., 2010)). Four genes involved 
in the DSB repair pathway, BRCA1, BRCA2, MRE11 and PRDKC (gene encoding DNA-PKcs) 
were each mutated in two cancers and one mutation each in the genes encoding FANCA, 
FANCG and FANCM, PABL2, WRN, XRCC 1, XPB, XPF. XPG, RAD23A was identified. In a 
more controlled study involving the analysis of a limited set of DNA repair and cell cycle 
checkpoint genes in 188 lung adenocarcinomas and 91 glioblastomas, the NHEJ mutation in 
PRDKC and mismatch repair gene MSH6 were each mutated in six and four cases 
respectively. The HR repair genes BRCA2, BAP1 and BARD1 were mutated in two cases 
each. Mutations in ATM were also identified in a few cases of lung adenocarcinomas. 
Notably, although large scale genome sequencing projects identified mutations in the genes 
involved in DNA repair, such mutations were detected only in a small proportion of human 
cancers (Negrini et al., 2010). 
5.4.3 DDR and oncogene-induced senescence 
An alternative model has been proposed that postulates that DDR, in fact, acts as a barrier to 
cellular transformation in the early stages of tumor progression by preventing the 
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accumulation of mutations in the face of activated oncogenes (Bartek et al., 2007). According 
to this idea, the first hallmark to be acquired in sporadic cancer might be activated growth 
factor signalling owing to mutations in oncogenes and loss of tumor suppressor genes 
(Negrini et al., 2010). This results in an increased cell proliferation rate which generates a 
DNA replication stress, as shown for several oncogenes like Ras, Myc, Stat3 and E2FF1 
(Bartkova et al., 2006). DNA replication stress, in turn, creates a high level of DNA damage, 
which results in the persistent activation of the DDR in the form of activated ATM/ATR 
signalling cascade causing cell death or senescence of incipient cancer cells. The senescence 
pathway evoked by oncogenes upon hyper-activation is now commonly referred to as the 
oncogene-induced senescence and is recognised as an important barrier to tumor 
progression (Gorgoulis and Halazonetis, 2010). Consistent with this idea, human lung, skin 
and colon precancerous lesions, show both apoptosis and senescence at the early stages of 
tumor development, whereas these processes are actively suppressed during cancer 
progression. Endogenous oncogenic K-Ras (K-Ras G12V) was shown to trigger senescence 
during the early stages of lung and pancreatic tumorigenesis. Melanocyte senescence has 
also been associated with the presence of oncogenic BRAFV60E, an oncogenic form of BRAF, 
in vivo (Michaloglou et al., 2005). Similarly, human prostate intraepithelial neoplasia (PIN) 
lesions and premalignant human colon adenomas display features of cellular senescence. 
Loss of the tumor suppressor neurofibromin 1 (NF 1), a Ras GTPase-activating protein that 
negatively regulates Ras, also leads to cellular senescence. By sharp contrast, senescence was 
absent in the corresponding malignant stages of human lung adenocarcinomas, pancreatic 
ductal adenocarcinomas, prostate adenocarcinoma and melanomas, suggesting that 
senescence acts as a barrier to tumor development. It is proposed that breaches to this anti-
cancer barrier, arising due to mutational or epigenetic inactivation of DDR components help 
in the evasion of senescence and are subsequently selected for during tumor development. 
5.4.4 DDR in cancer stem cells 
Gaining a better understanding of the role of DDR in cancer cells is also important from a 
standpoint of therapy, since most chemotherapeutic compounds are DNA damaging agents. 
Many human cancers including leukemia, glioblastoma, breast and skin cancers contain a 
small proportion of cells which are functionally similar to tissue-stem cells, but have 
aberrant self-renewal and differentiation characteristics and these have been called as cancer 
stem cells (CSCs) (Clarke and Fuller, 2006). Recent studies have suggested that CSCs are 
responsible for disease progression and tumor relapse after therapy, since they may take 
advantage of the DNA repair systems used by tissue-stem cells to achieve resistance to 
chemotherapy/radiotherapy (Blanpain et al., 2011). Here, we discuss three instances where 
the DDR has been demonstrated to have an effect on the outcome of cancer therapy. In the 
first case, the CSCs of leukemias, which exist in both acute myeloid leukemia (AML) and 
chronic myelogenous leukemia (CML) have been shown to be more resistant to cancer 
therapies as compared to the bulk of the leukemia cells. Leukemia CSCs have been shown to 
use protective mechanisms similar to HSCs, such as cell cycle quiescence, and DDR 
mechanisms to escape chemotherapy. For example, p53-dependent induction of p21 and the 
resulting growth arrest has been found to be critical in protecting adult HSCs from IR 
(Mohrin et al., 2010)  and CSCs from leukemia co-opt similar protective mechanisms to 
evade apoptosis and during chemotherapy (Viale et al., 2009). There is also evidence that 
CSCs isolated from breast cancers (CD44 high, CD24 low cells) show resistance to 
chemo/and or radiotherapy.  Transcriptional profiling of murine mammary CSCs also 
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showed increased expression of several DDR and DNA repair genes (Zhang et al., 2008), 
suggesting that mammary gland CSCs may also be more resistant to therapy. Indeed, a 
comparison of tumor biopsies before and after neoadjuvant chemotherapy showed 
increased proportion of CSCs following chemotherapy. One possible mechanism seems to 
be that like normal mammary stem cells, CSCs from mammary gland have increased levels 
of genes regulating free radical scavenging systems, like those of glutathione metabolism 
(Diehn et al., 2009). Lastly, glioblastoma multiforme (GBM) represents the most aggressive 
form of brain tumor and CSCs are isolated from these tumors based on the expression of 
prominin (CD133-positive cells).  Upon irradiation, the proportion of CD133+ cells 
increased, suggesting that CSCs may be responsible for tumor relapse after radiotherapy 
(Bao et al., 2006). It was found that CSCs from GBM exhibited a more robust activation of 
DNA damage checkpoint and increased phosphorylation of ATM, Chk1 and Chk2 were 
observed in the CSCs as compared to the non-CSC counterparts. Consistently, treatment 
with Chk1/Chk2 inhibitors sensitized the CSC to IR-induced cell death. 
6. DNA repair and aging 
Aging involves a gradual deterioration of several physiological functions, resulting in the 
reduced capacity to repair injured organs, increased propensity to infections, cancer 
predisposition and decreased fecundity (DiGiovanna, 2000; Partridge and Mangel, 1999). 
Many hypotheses have been proposed to understand the underlying mechanisms of the 
aging process, and these include the disease theory, free radical theory and DNA damage 
accumulation theory. In this section, we only discuss evidences that support the relationship 
between DNA damage accumulation and aging, a concept proposed more than half century 
ago by Leo Szilard (Szilard, 1959). Throughout the life-span, cells are constantly exposed to 
different endogenous or exogenous conditions that lead to DNA lesions which trigger DNA 
damage checkpoint response and DNA repair signalling. The accumulation of 
unrepaired/unrepairable DNA damage within cells leads to a sustained DNA damage 
checkpoint response and induces a state called cellular senescence, wherein cells 
permanently exit from the cell cycle. Consistent with this idea, it has been documented that 
DNA damage in the form of DSB-specific foci containing γ-H2AX accumulate in senescent 
human cells, germ and somatic cells of aged mice, and in dermal fibroblasts from aged 
primates (Maslov and Vijg, 2009). Mouse models harbouring deficiency in DNA repair 
proteins, such as ATM, Ku70, Ku80, DNA ligase IV or Ercc1 also  show premature aging 
phenotypes, providing  evidence of a direct correlation between impaired DDR and 
premature aging (Hasty, 2005; Hoeijmakers, 2009). 
So far, the relationship between DNA damage accumulation and aging has gained 
maximum credibility through studies conducted on various human progeria syndromes. 
Progeria syndromes are genetic disorders where patients precociously develop features 
resembling natural aging. Interestingly, most of the reported progeria syndromes, including 
Werner syndrome (WS), Bloom’s syndrome (BS), Rothmund-Thomson syndrome (RTS), 
Cockayne syndrome type A and type B (CSA and CSB), Xeroderma pigmentosum (XP), 
Trichothiodystrophy (TTD) and Hutchinson-Gilford progeria syndrome (HGPS) were 
caused by mutations of genes that were directly or indirectly involved in DNA repair 
pathways. WS, BS and RTS are associated with defects in RecQ helicases, i.e. RECQL2 
(WRN), RECQL3 (BLM) and RECQL4 respectively, whereas CS, XP and TTD shared similar 
defects in NER pathway. RecQ helicases are a group of highly conserved proteins from 
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bacteria to humans. The roles of RecQ helicases in DNA metabolism, including DNA 
replication (Lebel et al., 1999), transcription (Balajee et al., 1999), repair (Cooper et al., 2000; 
Li and Comai, 2000) and recombination, have been extensively investigated and are 
demonstrated to be the underlying pathological basis of WS, BS and RTS. Most recently, 
delayed DNA damage checkpoint response and defective DNA repair were found to 
contribute to the progeria phenotypes in HGPS as well (Liu et al., 2005). 
Since WS closely resembles physiological aging, WS cells have been the subject of intense 
investigation to understand the biology and molecular mechanism of normal aging. WS is 
an autosomal recessive genetic disorder of “progeria in adulthood”, affecting about 10 in 
one million (Multani and Chang, 2007). Patients suffering from WS are usually born healthy, 
with obvious growth retardation from the second decade and other ageing-related features, 
including short stature, premature cataract, beaked nose, skin atrophy and alopecia, loss of 
adipose tissues, type II diabetes, osteoporosis, arteriosclerosis, hypogonadism and 
predisposition to cancer. WS patients typically die of early onset cardiovascular diseases or 
neoplasia in the fourth decade of life and have an average life expectancy of 47 years. Skin 
fibroblasts cultured from affected individuals develop accelerated senescence with increased 
chromosome aberrations (Melcher et al., 2000; Salk et al., 1981). By positional cloning, WRN 
was firstly linked to WS (Yu et al., 1996). Before the identification of LMNA mutations  
(see below) in atypical WS, WRN was the only protein implicated in WS. WRN belongs to 
the family of RecQ helicases, and is the only member with a specific exonuclease domain 
within the N-terminus (Gray et al., 1997; Huang et al., 1998). Physiological and functional 
interactions between WRN and other proteins suggest that it has crucial roles in  
DNA replication and repair. WRN interacts with proteins required for DNA replication, 
such as RPA (Brosh et al., 1999), PCNA (Lebel et al., 1999), FEN1 (Brosh et al., 2001) and 
DNA polymerase (Polǅ) (Kamath-Loeb et al., 2001). Studies from Lebel and colleagues 
(1999) indicated that WRN was involved in restoration of stalled replication forks. WRN 
also interacts with heterodimer of Ku70-Ku80, which is involved in NHEJ pathway, 
indicating its potential role in regulating DSB repair (Cooper et al., 2000; Li and Comai, 
2000). WRN also plays an important role in maintaining telomere integrity. It has been 
reported that WRN associates with three of the six members of telomere complex, including 
telomeric repeat binding factor 1/2 (TRF1/2) and POT1, to modulate exonuclease and 
helicase activities of WRN during telomeric metabolism (Machwe et al., 2004; Multani and 
Chang, 2007). Recently, lamin A/C mutations (A57P, R133L, L140R, and E578V) were also 
reported in autosomal dominant atypical WS where patients presented with more severe 
phenotypes compared to those associated with WRN (Chen et al., 2003; Csoka et al., 2004; 
Fukuchi et al., 2004).  
Bloom’s syndrome is another rare genetic disease characterized by dwarfism, sun-induced 
erythaema, type II diabetes, narrow face and prominent ears, infertility, benign and 
malignant tumors. Deaths usually result from neoplasia before the age of 30. RecQ helicase 
BLM is associated with BS, which is shown to be capable of regulating HR. Upon DNA 
damage, BLM forms discrete nucleoplasmic foci that co-localize with RAD51 as well as 
BRCA1-associated genome surveillance complex (BASC) containing BRCA1, MLH1, MRN 
complex and ATM in mammalian cells (Hickson, 2003). BLM is also involved in the correct 
localization and activation of topoisomerase IIIα (Wu et al., 2000). Deletion of Blm in mice 
results in early embryonic death by E13.5. Blm mutant embryos show growth retardation 
and Blm−/− ES cells have an elevated HR between sister chromatids (Chester et al., 1998; 
Guo et al., 2004). Goss et al (Goss et al., 2002) showed that haploinsufficiency of Blm caused 
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early development of lymphoma. In another example involving the XPF-XRCC1 
endonuclease, a patient bearing a severe XPF mutation presented with dramatic progeroid 
symptoms. A mouse model for this mutation was generated and expression data from this 
mouse indicated a shift towards reduced growth hormone/insulin-like growth factor 1 
(IGF1) signalling, a known regulator of lifespan. It was proposed that DNA damage 
accumulation re-allocates resources from growth to life extension by suppressing the 
somatotroph axis (Niedernhofer et al., 2006). 
Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare severe genetic disorder 
of early onset premature aging, also referred to as “progeria in childhood”. The prevalence 
is one out of 8 million. So far only about 100 patients have been reported, mainly in western 
world. Patients with HGPS can only survive for 12-16 years with a mean age of 13.4 years 
and are clinically characterized with early growth retardation, short stature, lipodystrophy, 
alopecia, stiff joints, osteolysis, dilated cardiomyopathy and atherosclerosis (Hennekam, 
2006; Pollex and Hegele, 2004). A recurrent, de novo, dominant point mutation (1824 CT) of 
LMNA gene was identified to be responsible for about 76% reported cases of HGPS. This 
mutation (G608G) activates a cryptic splicing donor signal in exon 11, leading to 150 
nucleotides deletion in mutant transcript and a 50-residue truncation in lamin A protein 
(Eriksson et al., 2003; Reddel and Weiss, 2004). The 50-residue truncation in lamin A 
removes the second proteolytic cleavage site of ZMPSTE24 but leaving the  CAAX motif 
unaffected. A detailed study demonstrated that the mutant allele only expressed about 80% 
transcripts of total lamin A from the same allele and ~40% of total lamin A from both alleles 
(Reddel and Weiss, 2004). Studies in HGPS cells and mice lacking Zmpste24, a 
metalloprotease processing prelamin A to its mature form, reveal that accumulation of 
progerin and unprocessed prelamin A leads to either delayed or reduced recruitment of 
necessary DNA repair proteins, such as 53BP1 and Rad51 to sites of double strand breaks 
(Liu et al., 2005). 
Cockayne syndrome is an autosomal recessive disorder with growth retardation, skin 
atrophy, sparse hair, cataract, neural system deterioration, but without cancer susceptibility. 
As described earlier (section 3.3), Cockayne syndrome proteins are involved in TCR.  
 
Human Syndrome 
Mutated 
Gene 
Phenotypes 
Disrupted 
DNA repair 
pathway 
Ataxia Telangiectasia 
(AT) 
ATM Cerebellar ataxia, telangiectases, oculomotor 
apraxia, predisposition to lymphoid 
malignancies, leukemias, immune defects, 
dilated blood vessel, infertility, metabolic 
defects, growth defects  
DSB repair, 
DNA damage 
signalling 
Ataxia Telangiectasia-
like disorder (A-TLD) 
MRE11 Ataxia, oculomotor apraxia, 
immunodeficiency 
DSB repair, 
DNA damage 
signalling 
Nijmegan break 
syndrome (NBS) 
NBS1 Microcephaly, immunodeficiency, growth 
defects, mental retardation, B cell 
lymphoma, facial dysmorphism 
DSB repair, 
DNA damage 
signalling 
NBS-like syndrome RAD50 Microcephaly, facial dysmorphism, growth 
defects 
DSB repair, 
DNA damage 
signalling 
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Human Syndrome 
Mutated 
Gene 
Phenotypes 
Disrupted 
DNA repair 
pathway 
RIDDLE syndrome RNF168 Radiosensitivity,immunodeficiency, 
dysmorphic features and learning 
difficulties 
DSB repair, 
DNA damage 
signalling 
Primary 
microcephaly 1 
MCPH1/BR
IT1 
Microcephaly and mental retardation DSB repair, 
DNA damage 
signalling 
Seckel Syndrome ATR, 
PCTN, 
SCKL2, 
SCKL3 
Severe intrauterine growth retardation, 
profound microcephaly, a ‘bird-like’ facial 
profile, mental retardation and isolated 
skeletal abnormalities dysmorphic facial 
features 
DSB repair, 
DNA damage 
signalling 
Restrictive 
dermopathy (RD) 
LMNA, 
ZMPSTE24
Tight adherent skin, joint contractures and 
respiratory insufficiency, features of 
progeroid syndromes and premature death 
during gestation 
DSB repair 
Hutchinson-Gilford 
progeria syndrome 
LMNA Progeria (early growth retardation, short 
stature, lipodystrophy, alopecia, stiff joints, 
osteolysis, dilated cardiomyopathy and 
atherosclerosis) 
DSB repair, 
DNA damage 
signalling 
Li-Fraumeni syndrome TP53 Brain, breast cancer, sarcomas,   leukemias, 
melanomas and gastrointestinal cancers 
DNA damage 
signalling 
Xeroderma 
pigmentosum 
XPA-XPG, 
POL H 
Skin cancer, photosensitivity, 
neurodegeneration and microcephaly 
NER 
Trichothiodystrophy XPB, XPD, 
TTDA 
Neurodegeneration, hypomyelination, 
progeria (cachexia, cataracts, osteoporosis), 
microcephaly, and psychomotoric 
abnormalities. 
NER 
Cockayne syndrome CSA, CSB, 
XPB, 
XPD,XPG 
Microcephaly, neurodegeneration, neuronal 
demyelination, microcephaly, progeria (skin 
atrophy, sparse hair cachexia, cataracts, 
hearing loss, retinopathy), photosensitivity, 
growth defects 
NER 
Cerebro-oculo-facio-
skeletal (COFS) 
syndrome 
XPD, XPG, 
CSB, 
ERCC1 
Neuronal demyelination and 
dysmyelination, brain calcification, 
microcephaly, neurodegeneration, progeria 
(cataracts, hearing loss, retinopathy), 
photosensitivity, growth defects and facial 
dysmorphism  
NER 
Ataxia with 
oculomotor apraxia 1 
(AOA1) 
APTX Ataxia, neurodegeneration, oculomotor 
apraxia, hypercolesterolemia and dysarthria
SSB repair 
Spinocerebeller ataxia 
with axonal 
neuropathy (SCAN1) 
TDP1 Ataxia, oculomotor apraxia, cerebellar 
atrophy, dysarthria, hypercholesterolemia, 
muscle weakness, sensory neuropathy 
SSB repair 
Immunodeficiency 
with microcephaly  
XLF Growth delay, recurrent infections, 
autoimmunity, hypoglobulinemia, 
lymphopenia and microcephaly 
NHEJ 
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Human Syndrome 
Mutated 
Gene 
Phenotypes 
Disrupted 
DNA repair 
pathway 
Ligase IV syndrome LIG4 Microcephaly, developmental and growth 
delay, immunodeficiency 
(Aggamaglobulinemia, lymphopenia) and 
lymphoid malignancies 
NHEJ 
Radiosensitive  severe 
combined 
immunodeficiency 
(RS-SCID) 
ARTEMIS Aggamaglobulinemia, lymphopenia, 
growth defects 
NHEJ 
Severe combined 
immunodeficiency 
(SCID) 
RAG1, 
RAG2 
Aggamaglobulinemia, lymphopenia, 
growth defects 
NHEJ 
Bloom syndrome BLM Microcephaly, short stature, dysmorphic 
feature, elevated predisposition to all 
cancers, mild/moderate mental retardation, 
immunoglobulin deficiency, infertility, 
growth defects 
HR 
Werner syndrome WRN Premature aging (short stature, premature 
cataract, beaked nose, skin atrophy and 
alopecia, loss of adipose tissues) type II 
diabetes, osteoporosis, arteriosclerosis, 
hypogonadism and predisposition to cancer
HR, BER, 
telomere 
maintenance 
Rothmund Thomson  
syndrome (RTS) 
RECQL4 Stunted growth, premature aging (cataracts, 
grey hair), osteosarcomas, skin cancers, skin 
and skeletal abnormalities 
BER 
Early onset breast 
cancer 
BRCA1 Breast and ovarian cancer HR 
Early onset breast 
cancer 
BRCA2 Breast and ovarian cancer, increased 
predisposition to prostrate, gastric, 
pancreatic cancers and melanoma 
HR 
Fanconi anemia FANCA-
FANCL, 
BRCA2 
(FANCD1) 
Congenital abnormalities, pancytopenia, 
microcephaly, AML, myelodysplasia, 
squamous cell carcinoma of head and neck, 
abnormal skin pigmentation, infertility, 
limb deformities, renal dysfunction 
ICL repair 
and HR 
Hereditary non-
polyposis colorectal 
cancer (HNPCC) 
MSH2, 
MSH3, 
MSH6, 
MLH1, 
PMS2 
Colon and gynaecological cancers MMR 
Dyskeratosis 
congenita (DKC) 
DKC1, 
TERC 
Progeria (progressive bone marrow failure, 
pancytopenia, growth defects, 
osteoporosis), abnormal skin pigmentation, 
microcephaly, mental retardation  
carcinomas 
Telomere 
maintenance 
Table 1. Human diseases and syndromes caused by defective DNA repair 
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7. Conclusions and future directions 
Much of our current understanding of mammalian DNA damage signalling, checkpoint and 
repair is based on elegant experiments done using yeast and Xenopus as models. During the 
past decade, greater insights into the mechanism/regulation of the DDR were obtained 
using mouse models and human congenital disorders. It is now clear that the DDR pathway 
is critical for both repairing DNA lesions arising from genotoxic stress, as well as for several 
developmental processes like VDJ recombination, CSR, SHM and meiosis. Through 
extensive studies conducted in mouse models and human syndromes, it is now known that 
the principle phenotypes manifested in diseases associated with defective DNA repair are 
immunodeficiency, infertility, growth retardation, neurodegeneration, microcephaly, 
increased cancer predisposition and premature aging. Even so, some caveats in our 
knowledge exist that need further research. The molecular basis for certain phenotypes 
associated with DNA repair-related human diseases are not clear. For example, the learning 
difficulty in RIDDLE patients harbouring mutations in RNF168, skeletal abnormalities in 
ATR-defective Seckel syndrome and Fanconi anemia patients or insulin resistance and 
glucose intolerance in ATM-defective patients are some of the phenotypes not fully 
understood. Perhaps, some of these outcomes are related to tissue-specific novel effectors of 
the DDR pathway, and future studies are required in this direction. In this regard, it is really 
interesting that some unexpected substrates of the ATM/ATR pathway were uncovered in 
an unbiased genome-wide proteomic screen and studies on these substrates are likely to 
shed light on how the DRR can profoundly influence certain tissue-specific phenotypes. 
Likewise, recent studies have revealed an amazing complexity in the DDR pathway of stem 
cells and it seems the mechanistic details of how tissue stem cells respond to DNA damage 
vary between different stem cells populations. Since tissue stem cells have a critical role in 
the maintenance of organ homeostasis, any disruption in the genomic integrity of stem cells 
is likely to elicit diseased states such neurodegeneration, cancer or premature aging, or other 
specific phenotypes depending on the stem cell from the tissue of origin. In this context, 
further studies are clearly required to gain a total understanding of the genome maintenance 
pathways in stem cells. 
Apart from providing an in-depth understanding of human diseases, understanding the 
complexity of the DDR pathway has been harnessed for therapeutic benefit against certain 
cancer subtypes. The proposed rationale is that the DNA repair pathways and their 
downstream cellular components have undergone genetic alterations in cancer cells 
resulting in drug resistance. Hence abrogating or modulating the DDR through the use of 
DDR inhibitors can sensitize cancer cells to chemotherapy (Al-Ejeh et al., 2010). The most 
successful example in support of this concept has been the use of PARP inhibitors to 
sensitize Brca-deficient tumors to chemotherapy by about 1000 fold due to excessive DSBs 
generated as a result of compromised HR (Bryant et al., 2005). The idea being that the 
enzyme PARP-1 binds SSBs and BER intermediates to facilitate these repair processes. But in 
HR-defective Brca1 or Brca2 tumors, PARP inhibitors become particularly toxic due to the 
accumulation of unrepaired DSBs, while PARP inhibition remains nontoxic to normal cells, 
due to availability of backup mechanisms. PARP inhibitors are currently undergoing clinical 
trials in Brca-deficient breast and ovarian cancers. Along similar lines, Chk1 inhibition 
sensitizes p53-deficient tumors to DNA damaging agents better than p53-wild type cells. 
Thus, both DNA damaging therapies and DDR-inhibitor therapies can be tailored to the 
needs of each patient, based on the genetic alteration detected in their tumors. 
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In conclusion, great strides have been made towards understanding the DDR and its 
regulation in the past decade. We now have a detailed understanding of how exactly normal 
cells maintain their genomic integrity when faced with DNA damaging agents. It is now 
known that the DDR network is critical for several important physiological processes and 
for human health as evident by the growing list of human syndromes known to be 
associated with defective DNA repair. The real future challenge lies in developing a more 
thorough understanding of the functioning and regulation of DDR across various cell/tissue 
types and then harnessing this knowledge to develop therapeutics for the better 
management of human health or, perhaps, even extend life span. 
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